<SEC-DOCUMENT>0001140361-24-037330.txt : 20240814
<SEC-HEADER>0001140361-24-037330.hdr.sgml : 20240814
<ACCEPTANCE-DATETIME>20240814162506
ACCESSION NUMBER:		0001140361-24-037330
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240812
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240814
DATE AS OF CHANGE:		20240814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OCCIDENTAL PETROLEUM CORP /DE/
		CENTRAL INDEX KEY:			0000797468
		STANDARD INDUSTRIAL CLASSIFICATION:	CRUDE PETROLEUM & NATURAL GAS [1311]
		ORGANIZATION NAME:           	01 Energy & Transportation
		IRS NUMBER:				954035997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-09210
		FILM NUMBER:		241208416

	BUSINESS ADDRESS:	
		STREET 1:		5 GREENWAY PLAZA
		STREET 2:		SUITE 110
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77046
		BUSINESS PHONE:		7132157000

	MAIL ADDRESS:	
		STREET 1:		5 GREENWAY PLAZA
		STREET 2:		SUITE 110
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77046
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ny20033325x5_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:oxy="http://oxy.com/20240812" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.6.2.5244
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_170e89047b0b404da62c60da4a9e789a" contextRef="c20240812to20240812" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_c977ddd69e14458782b8e853310497dc" contextRef="c20240812to20240812">0000797468</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="oxy-20240812.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20240812to20240812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000797468</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-12</xbrli:startDate><xbrli:endDate>2024-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240812to20240812_StatementClassOfStockAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000797468</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-12</xbrli:startDate><xbrli:endDate>2024-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240812to20240812_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock020ParValueMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000797468</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">oxy:WarrantsToPurchaseCommonStock020ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-12</xbrli:startDate><xbrli:endDate>2024-08-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.6pt; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.65pt; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.65pt; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 17%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.65pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.65pt; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_18534b9f77cd4fac8e23ebb93fd5f0ba" contextRef="c20240812to20240812">8-K</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 17%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.7pt; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.65pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d)</div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.65pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of the Securities Exchange Act of 1934</div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.65pt; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_13b34413fb5f45eeb540330f8e2ef898" contextRef="c20240812to20240812" format="ixt:date-monthname-day-year-en">August 12, 2024</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 17%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.8pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 24pt;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_bd24ba0eae264f12a2af6ccef55e85cf" contextRef="c20240812to20240812">OCCIDENTAL PETROLEUM CORPORATION</ix:nonNumeric></span><br/>
      </div>

      <div style="text-align: center; margin-right: 41.7pt; margin-left: 42.8pt; font-family: 'Times New Roman'; font-size: 10pt;">(Exact Name of Registrant as Specified in its Charter)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
<div>&#160;
        </div>
<hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 17%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 35.44%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_41bf4f1e59804a5a8fda037e5ad13780" contextRef="c20240812to20240812" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33.7%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_2a4341f3ad3d499b86cc2659bc2dffa3" contextRef="c20240812to20240812">1-9210</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 30.86%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_5663ed0b9a1947d09b641ee0dbe8adcc" contextRef="c20240812to20240812">95-4035997</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 35.44%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(State or Other Jurisdiction </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of Incorporation)</div>
            </td>

    <td style="width: 33.7%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Commission</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> File Number)</div>
            </td>

    <td style="width: 30.86%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;(IRS Employer </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_68f1b567fc784dcaa228f77c386667f4" contextRef="c20240812to20240812">5 Greenway Plaza</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_22e52c80c8fc49b1b10b401e9665238d" contextRef="c20240812to20240812">Suite 110</ix:nonNumeric></div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_82768a9586934926a3e70c6d37c27c59" contextRef="c20240812to20240812">Houston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_e6ac5b56f079477787929f50eed90a6f" contextRef="c20240812to20240812" format="ixt-sec:stateprovnameen">Texas</ix:nonNumeric></div>
            </td>

    <td style="width: 50%; vertical-align: bottom; text-align: center;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_c37957287bfe4a0f9cf664ae2d2dddab" contextRef="c20240812to20240812">77046</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; margin-right: 1.05pt; font-weight: bold;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; margin-right: 143.95pt; margin-left: 143.05pt; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s Telephone Number, Including Area Code: <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_7ea8e735387046fd85094d07f7d75322" contextRef="c20240812to20240812">713</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_514e5c49c8f3496ab63bf2fc9d16452b" contextRef="c20240812to20240812">215-7000</ix:nonNumeric> </span></div>

      <div style="text-align: center; margin-right: 143.95pt; margin-left: 143.05pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;"> <br/>
        </span></div>

      <div style="text-align: center; margin-right: 143.95pt; margin-left: 143.05pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">Not Applicable</span></div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.75pt; font-family: 'Times New Roman'; font-size: 10pt;">(Former Name or Former Address, if Changed Since Last Report)</div>

      <div style="text-align: left; margin-right: 7.1pt; margin-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; margin-right: 7.1pt; margin-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 17%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: left; margin-right: 7.1pt; margin-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_19c851fbc23f4488977023bfb3b416e6" contextRef="c20240812to20240812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_ba8f53a94ad44e28a93f5b323dc15a0b" contextRef="c20240812to20240812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_b595991295c6456fbfb2bf64ae7f528a" contextRef="c20240812to20240812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
                    CFR 240.14d-2(b))</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_6ebe48624693476884f22123ed9c8744" contextRef="c20240812to20240812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
                  </span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
                    CFR 240.13e-4(c))</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 42.89%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">Title of Each Class</div>
            </td>

    <td style="width: 28.54%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">Trading Symbol(s)</div>
            </td>

    <td style="width: 28.56%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">Name of Each Exchange on Which </div>
              <div style="text-align: center;">Registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 42.89%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_5c5001f9a66c45a8aba6a1d9a88eeba1" contextRef="c20240812to20240812_StatementClassOfStockAxis_CommonStockMember">Common Stock, $0.20 par value</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 28.54%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_94f287e233ac40fd97fffd47fde0d8f7" contextRef="c20240812to20240812_StatementClassOfStockAxis_CommonStockMember">OXY</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 28.56%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_d9c45d99ea2d47b1bc8992a924a3e385" contextRef="c20240812to20240812_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock020ParValueMember" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 42.89%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_59cf342c605a482fbc66f16234c42354" contextRef="c20240812to20240812_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock020ParValueMember">Warrants to Purchase Common Stock, $0.20 par value</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 28.54%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_233d4db371bb41d9bd38efd29899e9a0" contextRef="c20240812to20240812_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock020ParValueMember">OXY WS</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 28.56%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_8fb9967ecf5e4e1ba49ac1157d6883e3" contextRef="c20240812to20240812_StatementClassOfStockAxis_CommonStockMember" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the
        Securities Exchange Act of 1934 (17 CFR 240.12b-2).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_f4905e8ecbea44ac93f22d1b4ca8914e" contextRef="c20240812to20240812" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
<div>&#160;<br/></div>

        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 8.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Other Events</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Underwriting Agreement</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; color: rgb(0, 0, 0);">On August 12, 2024, Occidental Petroleum Corporation (the &#8220;Company&#8221;), CrownRock Holdings, L.P. (the &#8220;Selling Stockholder&#8221;), J.P. Morgan Securities LLC, Morgan Stanley &amp; Co. LLC and RBC
          Capital Markets, LLC (collectively, the &#8220;Underwriters&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) pursuant to which the Selling Stockholder agreed to sell to the Underwriters, and the Underwriters agreed to purchase
          from the Selling Stockholder, subject to and upon the terms and conditions set forth therein, 29,560,619 shares of the Company&#8217;s common stock, par value $0.20 per share&#160; (the &#8220;Offering&#8221;).</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: justify; color: rgb(0, 0, 0);">The Offering was made pursuant to the Company&#8217;s registration statement on Form S-3 (Registration No. 333-281228) (the &#8220;Registration Statement&#8221;) that became effective when filed with the U.S.
          Securities and Exchange Commission on August 2, 2024, a prospectus included in the Registration Statement, and a preliminary prospectus supplement and final prospectus supplement, each dated August 12, 2024.<br/>
          <br/>
          The Offering closed on August 14, 2024. The Company did not sell any of its shares of common stock in the Offering and the Company will not receive any of the proceeds from the Offering.<br/>
          <br/>
          The Underwriting Agreement contains customary representations, warranties and covenants, customary conditions to closing, indemnification obligations of the Company, the Underwriters and the Selling Stockholder, including for liabilities under
          the Securities Act of 1933, as amended, and other obligations of the parties. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were
          solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its
          entirety by reference to the copy thereof, which is filed herewith as Exhibit 1.1 and is incorporated herein by reference.</div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <div><br/>
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;"> Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: -54pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">(d) <span style="font-style: italic;">Exhibits</span>.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);"><a href="ny20033325x5_ex1-1.htm">1.1</a></div>
            </td>

    <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left;">Underwriting Agreement, dated August 12, 2024, among Occidental Petroleum Corporation, CrownRock Holdings, L.P., J.P. Morgan Securities LLC, Morgan Stanley &amp; Co. LLC and RBC Capital Markets, LLC.</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 95%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">104</div>
            </td>

    <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0);">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; margin-right: 43.5pt; margin-left: 42.65pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; text-indent: 36pt; margin-right: 7.1pt; margin-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report
        to be signed on its behalf by the undersigned hereunto duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">August 14, 2024</div>
            </td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">OCCIDENTAL PETROLEUM CORPORATION</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left;">By:</div>
            </td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left;">/s/ Nicole E. Clark</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Name:</div>
            </td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Nicole E. Clark</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Title:</div>
            </td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Vice President, Chief Compliance Officer and Corporate Secretary</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ny20033325x5_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Soultions, Inc.
         Document created using Broadridge PROfile 24.6.2.5244
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
      <div>
        <div style="text-align: right; font-weight: bold;">Exhibit 1.1</div>
        <div style="text-align: right; font-weight: bold;"> <br>
        </div>
        <div style="text-align: right; font-weight: bold;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic; font-weight: bold;">Execution Version</div>
        </div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">29,560,619 Shares</div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">OCCIDENTAL PETROLEUM CORPORATION.</div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">COMMON STOCK, PAR VALUE $0.20 PER SHARE</div>
        <div>&#160;</div>
        <div style="text-align: center; font-weight: bold;">UNDERWRITING AGREEMENT</div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div style="text-align: right;">&#160;August 12, 2024</div>
        <div style="text-align: right;"> <br>
        </div>
        <div>J.P. Morgan Securities LLC</div>
        <div>383 Madison Avenue</div>
        <div>New York, New York 10179</div>
        <div><br>
        </div>
        <div>Morgan Stanley &amp; Co. LLC</div>
        <div>1585 Broadway</div>
        <div>New York, New York 10036</div>
        <div><br>
        </div>
        <div>RBC Capital Markets, LLC</div>
        <div>Three World Financial Center</div>
        <div>200 Vesey Street</div>
        <div>New York, New York 10281-8098</div>
        <div><br>
        </div>
        <div style="text-align: justify; margin-left: 36pt;">as Representatives of the several Underwriters</div>
        <div>&#160;</div>
        <div style="text-align: justify;">Ladies and Gentlemen:</div>
        <div>&#160;</div>
        <div style="text-indent: 27pt;">&#160;&#160; Occidental Petroleum Corporation, a Delaware corporation (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), confirms its agreement (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;) with the
          underwriters listed on <u>Schedule A</u> (collectively, the &#8220;<font style="font-weight: bold;">Underwriters</font>,&#8221; which term also includes any underwriter substituted as hereinafter provided in Section 12) and certain stockholders of the
          Company listed on <u>Schedule C</u> (the &#8220;<font style="font-weight: bold;">Selling Stockholder</font>&#8221;) with respect to the sale by the Selling Stockholder to the Underwriters of an aggregate of 29,560,619 shares (the &#8220;<font style="font-weight: bold;">Shares</font>&#8221;) of the Company&#8217;s common stock, par value $0.20 per share (the &#8220;<font style="font-weight: bold;">Common Stock</font>&#8221;). You will be the representatives of the several Underwriters (the &#8220;<font style="font-weight: bold;">Representatives</font>&#8221;).



          To the extent there are no additional Underwriters listed on Schedule A other than you, the term Representatives as used herein shall mean you, as Underwriter, and the terms Representatives and Underwriters shall mean either the singular or
          plural as the context requires.</div>
        <div style="text-indent: 27pt;">&#160;</div>
        <div style="text-indent: 27pt;">&#160;&#160; The Company has filed with the U.S. Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">Commission</font>&#8221;) a registration statement on Form S-3ASR (No. 333-281228) for the registration of
          the Shares, under the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold;">1933 Act</font>&#8221;), and the offering thereof from time to time in accordance with Rule 415 of the rules and regulations of the Commission under the
          1933 Act (the &#8220;<font style="font-weight: bold;">1933 Act Regulations</font>&#8221;). Such registration statement became effective upon filing with the Commission pursuant to Rule 462(e) of the 1933 Act Regulations. Such registration statement (as
          amended by any subsequent post-effective amendments thereto) and the prospectus dated August 2, 2024 (the &#8220;<font style="font-weight: bold;">Base Prospectus</font>&#8221;), together with the final prospectus supplement dated August 12, 2024 (the &#8220;<font style="font-weight: bold;">Final Prospectus Supplement</font>&#8221;) relating to the Shares, including, in each case, all Incorporated Documents (as hereinafter defined) and, solely in the case of any such registration statement, the information
          that is deemed pursuant to Rule 430B of the 1933 Act Regulations to be part of such registration statement (&#8220;<font style="font-weight: bold;">Rule 430B Information</font>&#8221;), are referred to herein as the &#8220;<font style="font-weight: bold;">Registration




            Statement</font>&#8221; and the &#8220;<font style="font-weight: bold;">Prospectus</font>,&#8221; respectively, except that, if any revised prospectus or any revised or additional prospectus supplement filed by the Company is provided to the Underwriters by the
          Company for use in connection with the offering of the Shares (including for delivery upon request of purchasers of Shares pursuant to Rule 173 of the 1933 Act Regulations), the term &#8220;<font style="font-weight: bold;">Prospectus</font>&#8221; will refer
          to such revised prospectus or any such revised or additional prospectus supplement, as the case may be, from and after the time it is first provided to the Underwriters for such use.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%%%-->
        <div style="text-indent: 27pt;">&#160;&#160; As used herein, the term &#8220;preliminary prospectus&#8221; means any prospectus supplement filed by the Company relating to the Shares that is captioned &#8220;Subject to Completion&#8221; or &#8220;preliminary prospectus supplement&#8221; or
          that has a similar caption, together with the Base Prospectus, including all Incorporated Documents, it being understood that all references herein to a &#8220;preliminary prospectus&#8221; include, without limitation, the Statutory Prospectus (as defined
          below). Any reference herein to the Registration Statement, any preliminary prospectus or the Prospectus is deemed to refer to and include the documents, financial statements and schedules incorporated, or deemed to be incorporated, by reference
          therein (other than information in&#160; such documents, financial statements and schedules that is deemed not to be filed) pursuant to Item 12 of Form S-3ASR under the 1933 Act, and any reference to any amendment or supplement to the Registration
          Statement, any preliminary prospectus or the Prospectus is deemed to refer to and include any documents, financial statements and schedules filed by the Company with the Commission under the Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">1934 Act</font>&#8221;), and so incorporated, or deemed to be incorporated, by reference (other than information in such documents, financial statements and schedules that is deemed not to be filed) (such incorporated
          documents, financial statements and schedules being herein called the &#8220;<font style="font-weight: bold;">Incorporated Documents</font>&#8221;). Notwithstanding the foregoing, for purposes of this Agreement, any prospectus supplement prepared or filed
          with respect to an offering pursuant to the Registration Statement of any securities other than the Shares will not be deemed to have supplemented any preliminary prospectus or the Prospectus and the information therein will not be deemed Rule
          430B Information. For purposes of this Agreement, all references to the Registration Statement, the Prospectus or any preliminary prospectus, or to any Issuer Free Writing Prospectus, Issuer General Use Free Writing Prospectus or Issuer Limited
          Use Free Writing Prospectus (as such terms are hereinafter defined) or to any amendment or supplement to any of the foregoing are deemed to include any copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and
          Retrieval system (&#8220;<font style="font-weight: bold;">EDGAR</font>&#8221;).</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The Company and the Selling Stockholder understand that the Underwriters propose to make a public offering of the Shares as soon as the Underwriters deem advisable after this Agreement has been executed and
          delivered.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%%%-->
        <table cellspacing="0" cellpadding="0" id="zcf11603a1689487a8164c0ebdd9d54e3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 1.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Representations and Warranties of the Company</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The Company represents and warrants to each of the Underwriters as of the date hereof, as of the Applicable Time (as defined below) and as of the Closing Time referred to in Section 3(b), as follows:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Offering Qualifications</font>. (i) At the respective times of filing the Registration Statement and any
          post-effective amendments thereto,</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the 1933 Act
          (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the 1934 Act or form of prospectus), and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) of
          the 1933 Act Regulations) made any offer relating to the Shares in reliance on the exemption of Rule 163 of the 1933 Act Regulations:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160; the Company was or is (as the case may be) a &#8220;well-known seasoned issuer,&#8221; as defined in Rule 405 of the 1933 Act
          Regulations (&#8220;<font style="font-weight: bold;">Rule 405</font>&#8221;), including not having been and not being an &#8220;ineligible issuer&#8221; as defined in Rule 405;</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Registration Statement is an &#8220;automatic shelf registration statement,&#8221; as defined in Rule 405, that initially became
          effective within three years of the date of this Agreement; and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160; the Company has not received from the Commission any notice pursuant to Rule 401(g)(2) of the 1933 Act Regulations objecting
          to the use of the automatic shelf registration statement form.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Not Ineligible</font>. At the earliest time after the filing of the Registration Statement that the
          Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the 1933 Act Regulations) of the Shares, the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405, without taking account
          of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an &#8220;ineligible issuer.&#8221;</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Incorporated Document Compliance</font>. The Incorporated Documents, when they were filed (or, if an
          amendment with respect to any such Incorporated Document was filed, when such amendment was filed) with the Commission, as the case may be, complied in all material respects with the requirements of the 1934 Act and the rules and regulations of
          the Commission under the 1934 Act (the &#8220;<font style="font-weight: bold;">1934 Act Regulations</font>&#8221;), and any Incorporated Documents filed subsequent to the date of this Agreement will, when they are filed with the Commission, comply in all
          material respects with the requirements of the 1934 Act and the 1934 Act Regulations.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;"> Registration Statement and Prospectus Compliance</font>. (i) The Registration Statement, at (A) its
          original effective date and the effective date of each post-effective amendment thereto, if any, and (B) each deemed effective date with respect to the Underwriters pursuant to Rule 430B(f)(2) of the 1933 Act Regulations, complied and will comply
          in all material respects with the provisions of the 1933 Act and the 1933 Act Regulations and did not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make
          the statements therein not misleading, and</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Prospectus relating to the Shares, as of its date, as of the date of any supplement to the Prospectus and as of the
          Closing Time, complied and will comply in all material respects with the provisions of the 1933 Act and the 1933 Act Regulations and did not and will not contain an untrue statement of a material fact or omit to state a material fact required to
          be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were or will be made, not misleading.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">10b-5 Compliance and No Free Writing Prospectus Conflict.</font> (i) As of the Applicable Time, neither</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 72pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160; any Issuer General Use Free Writing Prospectus(es) issued at or prior to the Applicable Time, the Statutory Prospectus and the information included on <u>Schedule
            B-1</u> hereto, all considered together (collectively, the &#8220;<font style="font-weight: bold;">General Disclosure Package</font>&#8221;), nor</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 72pt;">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any individual Issuer Limited Use Free Writing Prospectus issued at or prior to the Applicable Time, when considered together with the General Disclosure Package,</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 72pt;">included any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the
          light of the circumstances under which they were made, not misleading.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Issuer Free Writing Prospectus complied and, except during such time, if any, as the Company shall have suspended
          the use of such Issuer Free Writing Prospectus as contemplated by Section 5(e)(ii), will comply with the requirements of Rule 433(c)(1) of the 1933 Act Regulations.</div>
        <div>&#160;</div>
        <div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; As used in this subsection and elsewhere in this Agreement:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Applicable Time</font>&#8221; means 5:00 p.m. (New York City time) on August 12, 2024 or such other time as agreed by the Company and the
          Representatives.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Issuer Free Writing Prospectus</font>&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 of the 1933 Act Regulations (&#8220;<font style="font-weight: bold;">Rule 433</font>&#8221;), relating to the Shares that (i) is required to be filed with the Commission by the Company, (ii) is a &#8220;road show&#8221; that constitutes a written communication within the meaning of Rule 433(d)(8)(i),
          whether or not required to be filed with the Commission or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Shares or of the offering thereof that does not reflect the final terms, in each case,
          in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Issuer General Use Free Writing Prospectus</font>&#8221; means any Issuer Free Writing Prospectus that is intended for general distribution to
          prospective investors, as evidenced by it being specified in <u>Schedule B-2</u>.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Issuer Limited Use Free Writing Prospectus</font>&#8221; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing
          Prospectus.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Statutory Prospectus</font>&#8221; means the Base Prospectus dated August 2, 2024 and the preliminary prospectus supplement dated August 12, 2024
          relating to the Shares, including the Incorporated Documents.</div>
        <div>&#160;</div>
        <div>The foregoing representations and warranties in subsection 1(d) (except as it relates to compliance as to form) and (e) do not apply to statements or omissions in the Registration Statement, any preliminary prospectus, any Issuer Free Writing
          Prospectus or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with information furnished to the Company in writing by or on behalf of the Underwriters through the Representatives expressly for use
          therein.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Documents Authorized and Accurately Summarized</font>. This Agreement has been duly authorized by the
          Company. The Common Stock, to the extent described in the General Disclosure Package or the Prospectus, is fairly and accurately summarized therein in all material respects.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">The Shares</font>. The authorized, issued and outstanding shares of capital stock of the Company are as
          set forth or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus (except for subsequent issuances, if any, pursuant to reservations, agreements or employee benefit plans referred to in the
          Registration Statement, the General Disclosure Package and the Prospectus or pursuant to the exercise of convertible securities or options referred to in the Registration Statement, the General Disclosure Package and the Prospectus); the
          outstanding shares of capital stock of the Company, including the Shares to be purchased by the Underwriters from the Selling Stockholder, have been duly authorized and validly issued and are fully paid and nonassessable; and none of the
          outstanding shares of capital stock of the Company, including the Shares to be purchased by the Underwriters from the Selling Stockholder, were issued in violation of any pre-emptive or similar rights of any securityholder of the Company, except
          for such violations (other than with respect to Shares to be purchased by the Underwriters from the Selling Stockholder) that are immaterial to the Company and its subsidiaries, taken as a whole.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">[Reserved]</font>.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Corporate Representations</font>. (i) The Company and each of Occidental Chemical Holding Corporation, a
          California corporation, OXY USA Inc., a Delaware corporation, Anadarko Petroleum Corporation, a Delaware corporation, and OxyRock, L.P., a Delaware limited partnership (&#8220;<font style="font-weight: bold;">OxyRock</font>&#8221;) (each, a &#8220;<font style="font-weight: bold;">Principal Domestic Subsidiary</font>&#8221; and, collectively, the &#8220;<font style="font-weight: bold;">Principal Domestic Subsidiaries</font>&#8221;) is validly existing and in good standing under the laws of their respective
          jurisdictions of organization.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and each Principal Domestic Subsidiary:</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160; has requisite corporate or other entity power and corporate or other entity authority to own its respective properties and carry on its respective business as
          presently conducted, as described in the General Disclosure Package and the Prospectus, and</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is duly registered or qualified to conduct business, and is in good standing, in each jurisdiction in which it owns or leases property or transacts business and
          in which such registration or qualification is necessary, except as to jurisdictions where the failure to do so would not have a material adverse effect on the Company and its subsidiaries, taken as a whole.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; All of the outstanding capital stock or other securities evidencing equity ownership or partnership interests, as the
          case may be, of each Principal Domestic Subsidiary:</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;have been duly authorized, validly issued and, in the case of capital stock, are fully paid and non-assessable, and</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160; in the case of the Company&#8217;s Principal Domestic Subsidiaries, and except as otherwise disclosed in the Registration Statement, the General Disclosure Package and
          the Prospectus, are owned by the Company, in each case, directly or indirectly through subsidiaries, free and clear of any security interest, claim, lien or encumbrance.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Material Adverse Change</font>. Except as contemplated in the General Disclosure Package and the
          Prospectus or reflected therein by the filing of any amendment or supplement thereto or any Incorporated Document, since the date of the most recent consolidated financial statements included or incorporated by reference in the Registration
          Statement, the General Disclosure Package and the Prospectus, there has not been any material adverse change, or any development that is reasonably likely to result in a material adverse change, in the consolidated financial condition or
          consolidated results of operations of the Company and its subsidiaries, taken as a whole.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">No Violation of Charter, Contracts or Orders</font>. The execution and delivery of this Agreement by the
          Company and the performance by the Company of its obligations under this Agreement do not and will not violate or constitute a breach of or a default (with the passage of time or otherwise) under:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Restated Certificate of Incorporation or Amended and Restated Bylaws of the Company, in each case, as amended,</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any agreement or instrument (which is, individually or in the aggregate, material to the Company and its subsidiaries,
          taken as a whole) to which the Company or any Principal Domestic Subsidiary is a party or by which any of them is bound or to which any of the property or assets of the Company or any Principal Domestic Subsidiary is subject, or</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; any order of any court or governmental agency or authority (which is, individually or in the aggregate, material to the
          Company and its subsidiaries, taken as a whole) presently in effect and applicable to the Company or any Principal Domestic Subsidiary.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(l)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Governmental Consents</font>. Except for orders, permits and similar authorizations required under the
          securities or Blue Sky laws of certain jurisdictions, including jurisdictions outside the United States, or required of the Financial Industry Regulatory Authority (&#8220;<font style="font-weight: bold;">FINRA</font>&#8221;) or the New York Stock Exchange,
          no consent, approval, authorization or other order of any regulatory body, administrative agency or other governmental body is legally required for the performance by the Company of its obligations under this Agreement.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Financial Statements</font>. The consolidated financial statements (including the related notes thereto)
          included in the Registration Statement, the General Disclosure Package and the Prospectus, or incorporated therein by reference, fairly present in all material respects the consolidated financial position and results of operations of the Company
          and its subsidiaries, or, to the Company&#8217;s knowledge, OxyRock and its subsidiaries, as applicable, at the respective dates and for the respective periods to which they apply. Such consolidated financial statements have been prepared in accordance
          with United States generally accepted accounting principles consistently applied, except as set forth in the Registration Statement, the General Disclosure Package and the Prospectus. The pro forma financial statements and the related notes
          thereto included in each of the Registration Statement, the General Disclosure Package and the Prospectus, or incorporated therein by reference, fairly present in all material respects the information shown therein, have been prepared in all
          material respects in accordance with the Commission&#8217;s applicable rules and guidelines with respect to pro forma financial statements and have been properly compiled on the bases described therein and, subject to the qualifications therein, the
          assumptions used in the preparation thereof are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein. The interactive data in eXtensible Business Reporting Language
          incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the required information in all material respects and has been prepared in accordance with the Commission&#8217;s rules and
          guidelines applicable thereto.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Disclosure Controls and Procedures</font>. The Company maintains &#8220;disclosure controls and procedures&#8221; (as
          defined in Rule 13a-15(e) of the 1934 Act) that are designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported within the time
          periods specified in the Commission&#8217;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding
          required disclosure. The Company has carried out evaluations of the effectiveness of its disclosure controls and procedures as required by Rule 13a-15 of the 1934 Act.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(o)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Internal Controls</font>. The Company maintains &#8220;internal control over financial reporting&#8221; (as defined in
          Rule 13a-15(f) of the 1934 Act) that has been designed by, or under the supervision of, its principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability
          of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and that include those policies and procedures that (i) pertain to the maintenance of records
          that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
          accordance with generally accepted accounting principles and that receipts and expenditures of the Company are being made only in accordance with the authorizations of management and the directors of the Company as applicable; (iii) provide
          reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material adverse effect on the Company&#8217;s financial statements; and (iv) provide reasonable
          assurance that the interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the required information in all material
          respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(p)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">No Unlawful Payments.&#160; </font>None of (x) the Company or any of its subsidiaries or (y) to the knowledge
          of the Company, any directors, officers, employees, agents, controlled affiliates or other persons acting on behalf of the Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or
          other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or
          employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or
          candidate for political office; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended (the &#8220;<font style="font-weight: bold;">FCPA</font>&#8221;), or any applicable law or regulation implementing the
          OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom (the &#8220;<font style="font-weight: bold;">U.K. Bribery Act</font>&#8221;), or
          any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence
          payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce, policies and procedures designed to promote and ensure
          compliance with all applicable anti-bribery and anti-corruption laws.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Compliance with Anti-Money Laundering Laws. </font>The operations of the Company and its subsidiaries are
          and have been conducted at all times in material compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money
          laundering statutes of all jurisdictions where the Company or any of its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any
          governmental agency (collectively, the &#8220;<font style="font-weight: bold;">Anti-Money Laundering Laws</font>&#8221;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the
          Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(r)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">No Conflicts with Sanctions Laws</font>. None of (x) the Company or any of its subsidiaries or (y) to the
          knowledge of the Company, any directors, officers, employees, agents, controlled affiliates or other persons acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or
          enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially
          designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury or other relevant sanctions authority (collectively, &#8220;<font style="font-weight: bold;">Sanctions</font>&#8221;), nor is the
          Company or any of its subsidiaries organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Cuba, Iran, the so-called Donetsk People&#8217;s Republic, the so-called Luhansk People&#8217;s
          Republic, the Crimea, Kherson and Zaporizhzhia regions of Ukraine, North Korea and Syria.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">Any certificate signed by any officer of the Company and delivered to the Underwriters, the Representatives or counsel for the Underwriters in connection with the transactions contemplated in this Agreement will be
          deemed a representation and warranty by the Company to the Underwriters as to the matters covered by such certificate as of its date.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zfc2e44580c2148b0aa67e47bbfbf0827" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 2.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-style: italic;">Representations and Warranties by the Selling Stockholder.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The Selling Stockholder represents and warrants to each of the Underwriters as of the date hereof, as of the Applicable Time (as defined below) and as of the Closing Time referred to in Section 3(b), as follows:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Registration Statement and Prospectus</font>. To the extent that any statements or omissions made in the
          Registration Statement, the General Disclosure Package, the Prospectus or any amendment or supplement thereto are made in reliance upon and in conformity with the Selling Stockholder Information (as defined below), such Registration Statement and
          General Disclosure Package did not, and the Prospectus and any further amendments or supplements to the Registration Statement and the Prospectus will not, when they become effective or are filed with the Commission, as the case may be, contain
          any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading. &#8220;<font style="font-weight: bold; font-style: italic;">Selling Stockholder
            Information</font>&#8221; consists solely of the information with respect to the Selling Stockholder furnished to the Company in writing by the Selling Stockholder expressly for use in the Registration Statement, the General Disclosure Package, the
          Prospectus or any amendment or supplement thereto, it being understood and agreed that such information is limited to the beneficial ownership table under the caption &#8220;Selling Stockholder&#8221; in the General Disclosure Package and the Prospectus.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Organization</font>. The Selling Stockholder has been duly formed and is validly existing and in good
          standing under the laws of its respective jurisdiction.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Authorization of this Agreement</font>. This Agreement has been duly authorized, executed and delivered by
          or on behalf of the Selling Stockholder.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">No Conflicts</font>. The execution and delivery of this Agreement and the sale and delivery of the Shares
          to be sold by the Selling Stockholder and the consummation of the transactions contemplated herein and compliance by the Selling Stockholder with its obligations hereunder do not and will not, whether with or without the giving of notice or
          passage of time or both, conflict with or constitute a breach of, or default under, or result in the creation or imposition of any tax, lien, charge or encumbrance upon the Shares to be sold by the Selling Stockholder or any property or assets of
          the Selling Stockholder pursuant to any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, license, lease or other agreement or instrument to which the Selling Stockholder is a party or by which the Selling Stockholder
          may be bound, or to which any of the property or assets of the Selling Stockholder is subject (except for such conflicts, breaches or defaults, or taxes, liens, charges or encumbrances that would not, individually or in the aggregate, reasonably
          be expected to materially impair the power or ability of the Selling Stockholder to perform its obligations under this Agreement, or to consummate the transactions contemplated hereby), nor will such action result in any violation of (A) the
          provisions of the charter or by-laws or other organizational instrument of the Selling Stockholder, if applicable, or (B) any applicable treaty, law, statute, rule, regulation, judgment, order, writ or decree of any government, government
          instrumentality or court, domestic or foreign, having jurisdiction over the Selling Stockholder or any of its properties, except in the case of clause (B) hereto for such violations that would not, individually or in the aggregate, reasonably be
          expected to materially impair the power or ability of the Selling Stockholder to perform its obligations under this Agreement or to contemplate the transaction contemplated hereby.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Valid Title</font>. The Selling Stockholder has, and at the Closing Time will have, valid title to the
          Shares to be sold by the Selling Stockholder free and clear of all security interests, claims, liens, equities or other encumbrances and the legal right and power, and all authorization and approval required by law, to enter into this Agreement
          and to sell, transfer and deliver the Shares to be sold by the Selling Stockholder or a valid security entitlement in respect of such Shares.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Delivery of Shares</font>. Upon payment for the Shares to be sold by the Selling Stockholder pursuant to
          this Agreement, delivery of such Shares, as directed by the Underwriters, to Cede &amp; Co. (&#8220;<font style="font-weight: bold;">Cede</font>&#8221;) or such other nominee as may be designated by The Depository Trust Company (&#8220;<font style="font-weight: bold;">DTC</font>&#8221;), registration of such Shares in the name of Cede or such other nominee and the crediting of such Shares on the books of DTC to securities accounts of the Underwriters (assuming that neither DTC nor any such Underwriter has
          notice of any adverse claim (within the meaning of Section 8-105 of the New York Uniform Commercial Code (the &#8220;<font style="font-weight: bold;">UCC</font>&#8221;) to such Shares), (A) DTC shall be a &#8220;protected purchaser&#8221; of such Shares within the
          meaning of Section 8-303 of the UCC, (B) under Section 8-501 of the UCC, the Underwriters will acquire a valid security entitlement in respect of such Shares and (C) no action based on any &#8220;adverse claim&#8221;, within the meaning of Section 8-102 of
          the UCC, to such Shares may be asserted against the Underwriters with respect to such security entitlement; for purposes of this representation, the Selling Stockholder may assume that when such payment, delivery and crediting occur, (x) such
          Shares will have been registered in the name of Cede or another nominee designated by DTC, in each case on the Company&#8217;s share registry in accordance with its certificate of incorporation, bylaws and applicable law, (y) DTC will be registered as
          a &#8220;clearing corporation&#8221; within the meaning of Section 8-102 of the UCC and (z) appropriate entries to the accounts of the several Underwriters on the records of DTC will have been made pursuant to the UCC.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Absence of Manipulation</font>. The Selling Stockholder has not taken and will not take, directly or
          indirectly, any action that is designed to or that might reasonably be expected to cause or result in unlawful stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Absence of Further Requirements</font>. No filing with, or consent, approval, authorization, order,
          registration, qualification or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency, domestic or foreign, is necessary or required for the performance by the Selling
          Stockholder of its obligations hereunder, or in connection with the sale and delivery of the Shares hereunder or the consummation of the transactions contemplated by this Agreement, except (A) such as have been already obtained or as may be
          required under the 1933 Act, the 1933 Act Regulations, the rules of the New York Stock Exchange, state securities laws or the rules of FINRA and (B) such consents, approvals, authorizations and orders for which a failure to obtain would not,
          individually or in the aggregate, reasonably be expected to materially impair the power or ability of the Selling Stockholder to perform its obligations under this Agreement or to consummate the transactions contemplated hereby.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">No Registration or Other Similar Rights. </font>The Selling Stockholder does not have any registration or
          other similar rights to have any equity or debt securities registered for sale by the Company under the Registration Statement or included in the offering contemplated by this Agreement other than those rights that have been disclosed in the
          Registration Statement, the General Disclosure Package and the Prospectus.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Issuer Free Writing Prospectus</font>. Other than the Registration Statement, the General Disclosure Package
          and the Prospectus, the Selling Stockholder (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use,
          authorize, approve or refer to any Issuer Free Writing Prospectus, other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the 1933 Act or Rule 134 under the 1933 Act or (ii) the documents listed on Schedule
          B, each road show and any other written communications approved in writing in advance by the Company and the Underwriters.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(k)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Taxes</font>. In order to document the Underwriters&#8217; compliance with the reporting and withholding provisions
          of the Tax Equity and Fiscal Responsibility Act of 1982 with respect to the transactions herein contemplated, the Selling Stockholder will deliver to the Representatives prior to or at the Closing Time a properly completed and executed United
          States Treasury Department Form W-8 or W-9 (or other applicable form or statement specified by Treasury Department regulations in lieu thereof).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Obligations of Selling Stockholder</font>. The obligations of the Selling Stockholder hereunder shall not
          be terminated by operation of law, whether by the dissolution of the Selling Stockholder or by the occurrence of any other event; if the Selling Stockholder shall be dissolved, or if any other such event should occur, before the delivery of the
          Shares to be sold by the Selling Stockholder hereunder, such Shares shall be delivered by or on behalf of the Selling Stockholder in accordance with the terms and conditions of this Agreement.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">[Reserved]</font>.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">No Association with FINRA</font>. Neither the Selling Stockholder, nor any of its affiliates, directly, or
          indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with any member firm of FINRA or is a person associated with a member (within the meaning of the FINRA By-Laws) of FINRA.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(o)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">No Unlawful Payments</font>. The Selling Stockholder will not directly or indirectly use the proceeds of
          the sale of the Shares, or lend, contribute or otherwise make available such proceeds to any subsidiaries, joint venture partners or other person, (i) to fund or facilitate any activities of or business with any person, or in any country or
          territory, that, at the time of such funding or facilitation, is the subject of Sanctions or in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter,
          advisor, investor or otherwise) of Sanctions or (ii) in furtherance of an offer, payment, promise to pay or authorization of the payment or giving of any money or anything of value to any person in contravention of the FCPA, the U.K. Bribery Act,
          any other applicable anti-bribery or anti-corruption law, or any Anti-Money Laundering Laws.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z073e94f525c74c65b7153aceb1b3a382" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 3.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Sale and Delivery to the Underwriters; Closing</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Purchase and Sale</font>. On the basis of the representations and warranties herein contained and subject
          to the terms and conditions herein set forth, the Selling Stockholder, agrees to sell to the several Underwriters, and each Underwriter, severally and not jointly, agrees to purchase from the Selling Stockholder the respective number of Shares
          set forth in <u>Schedule A</u> opposite the name of such Underwriter at $58.15 per share (the &#8220;<font style="font-weight: bold;">Purchase Price</font>&#8221;).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Closing Time</font>. Payment of the Purchase Price for, and delivery of, the Shares will be made at the
          offices of Weil, Gotshal &amp; Manges LLP, 767 Fifth Avenue, New York, New York 10153, or at such other place as will be agreed upon by the Underwriters and the Company, at 9:00 a.m. (New York City time) on August 14, 2024 (unless postponed in
          accordance with the provisions of Section 12), or such other time not later than ten business days after such date as is agreed upon by the Representatives and the Company (such time and date of payment and delivery being herein called &#8220;<font style="font-weight: bold;">Closing Time</font>&#8221;). Payment will be made to the Selling Stockholder by wire transfer of immediately available funds to the bank accounts designated by the Selling Stockholder, against delivery to the nominee of
          DTC, for the account of the Underwriters, of the Shares. It is understood that each Underwriter has authorized the Representatives for its respective account, to accept delivery of, and receipt for, and make payment of the Purchase Price for, the
          Shares which such Underwriter has agreed to purchase.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">No Fiduciary Relationship</font>. The Selling Stockholder and the Company, severally and not jointly,
          acknowledges and agrees that the Underwriters are acting solely in the capacity of an arm&#8217;s length contractual counterparty to the Selling Stockholder and the Company with respect to the offering of Shares contemplated hereby (including in
          connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Selling Stockholder, the Company or any other person. Additionally, neither the Representatives nor any other Underwriter
          is advising the Selling Stockholder, the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Selling Stockholder and the Company have consulted their own respective advisors
          concerning such matters to the extent they deemed appropriate, and the Underwriters will have no responsibility or liability to the Selling Stockholder or the Company with respect thereto. Any review by the Underwriters of the Selling
          Stockholder, the Company, the transactions contemplated hereby or any other matters relating to such transactions has been and will be performed solely for the benefit of the Underwriters and not on behalf of the Selling Stockholder or the
          Company.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z7b74d85677ea4d978f08991687943646" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 4.</td>
              <td style="vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Foreign Offerings</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">Each Underwriter, severally and not jointly, represents and agrees that:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;it has not solicited, and will not solicit, offers to purchase any of the Shares from,</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;it has not sold, and will not sell, any of the Shares to, and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; it has not distributed, and will not distribute, the General Disclosure Package or the Prospectus to any person or entity
          in any jurisdiction outside of the United States (collectively, &#8220;<font style="font-weight: bold;">Foreign Offers and Sales</font>&#8221;) except, in each case, in compliance in all material respects with all applicable laws and, in connection with the
          initial offering of, or subscription for, any of the Shares, in full compliance with the requirements and procedures, if any, established by, and subject to any exceptions granted by, the Company, in an email or other writing delivered to the
          Representatives, with respect to any such Foreign Offers and Sales. For the purposes of this paragraph, &#8220;<font style="font-weight: bold;">United States</font>&#8221; means the United States of America, its territories, its possessions (including the
          Commonwealth of Puerto Rico) and other areas subject to its jurisdiction.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">In particular and without limiting the generality of the foregoing:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Underwriter, severally and not jointly, agrees to distribute, in connection with any Foreign Offers and Sales, only
          those Prospectuses used in connection therewith that have been appropriately &#8220;stickered&#8221; for use in the jurisdiction in which such Foreign Offers and Sales are to be made.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With respect to the United Kingdom:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt;"><font style="color: rgb(0, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">[Reserved]</font></div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt;"><font style="color: rgb(0, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160; each Underwriter represents and agrees, severally and not jointly, that it has not offered, sold or otherwise made
          available and will not offer, sell or otherwise make available any Shares to any retail investor in the United Kingdom. For the purposes of this provision: (I) the expression &#8220;retail investor&#8221; means a person who is one (or more) of the following:
          (a) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (&#8220;<font style="font-weight: bold;">EUWA</font>&#8221;); (b) a customer
          within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of
          Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (c) not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA; and (II) the
          expression &#8220;offer&#8221; includes the communication in any form and by any means of sufficient information on the terms of the offer and the Shares to be offered so as to enable an investor to decide to purchase or subscribe for the Shares.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt;"> <br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each Underwriter has represented and agreed that it has not offered, sold or otherwise made available and will not offer,
          sell or otherwise make available any Shares to any retail investor in the European Economic Area. For the purposes of this provision: (I) the expression &#8220;retail investor&#8221; means a person who is one (or more) of the following: (a) a retail client
          as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;<font style="font-weight: bold;">MiFID II</font>&#8221;); (b) a customer within the meaning of Directive (EU) 2016/97 (as amended), where that customer would not qualify as
          a professional client as defined in point (10) of Article 4(1) of MiFID II; or (c) not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended); and (II) the expression &#8220;offer&#8221; includes the communication in any form and by any
          means of sufficient information on the terms of the offer and the Shares to be offered so as to enable an investor to decide to purchase or subscribe for the Shares.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z3ec582ce8d95403f86f1820f9b7536eb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 5.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Covenants of the Company and the Selling Stockholder</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The Company and the Selling Stockholder (solely with respect to Section 5(i)) covenants with each Underwriter as follows:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Notice of Certain Events</font>. During the period in which a prospectus relating to the Shares is
          required to be delivered under the 1933 Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), the Company will notify the Underwriters promptly of:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; the effectiveness of any post-effective amendment to the Registration Statement (other than a post-effective amendment
          relating solely to an offering of securities other than the Shares),</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; the transmittal to the Commission for filing of any supplement to any preliminary prospectus or the Prospectus (other than
          an amendment or supplement relating solely to an offering of securities other than the Shares) or any document to be filed pursuant to the 1934 Act which would be incorporated by reference in the Prospectus,</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160; &#160; the receipt of any comments from the Commission with respect to the Registration Statement, any Issuer Free Writing
          Prospectus, any preliminary prospectus or the Prospectus,</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160; any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the
          Prospectus, any preliminary prospectus or any Issuer Free Writing Prospectus or for additional information (other than any amendment or supplement to a prospectus relating solely to an offering of securities other than the Shares),</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the
          initiation of any proceedings for that purpose, and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; any examination pursuant to Section 8(e) of the 1933 Act concerning the Registration Statement or, if the Company becomes
          the subject of a proceeding under Section 8A of the 1933 Act, in connection with the offering of the Shares.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">If any stop order is issued, the Company will use its reasonable best efforts to obtain the lifting thereof at the earliest possible moment.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Payment of Commission Fees</font>.&#160; The Company has paid the required Commission filing fees relating to
          the Shares.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Notice of Certain Proposed Filings</font>. During the period in which a prospectus relating to the Shares
          is required to be delivered under the 1933 Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), the Company will:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; give the Underwriters advance notice of its intention to file any amendment to the Registration Statement or any amendment
          or supplement to any preliminary prospectus or the Prospectus (other than an amendment or supplement to a prospectus relating solely to an offering of securities other than the Shares),</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;furnish the Underwriters with copies of any such amendment or supplement, and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; not file any such amendment or supplement of which the Underwriters have not previously been advised or to which the
          Representatives reasonably object in writing, unless, in the judgment of the Company and its counsel, such amendment or supplement is necessary to comply with law.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Copies of the Registration Statement and the Prospectus</font>. The Company will deliver to each of the
          Underwriters one signed and as many conformed copies of the Registration Statement (as originally filed) and of each amendment thereto relating to the Shares (including the Incorporated Documents and any exhibits filed therewith or incorporated
          by reference therein) as the Underwriters may reasonably request. So long as delivery of a prospectus by an Underwriter or dealer may be required by the 1933 Act (including in circumstances where such requirement may be satisfied pursuant to Rule
          172), the Company will furnish to the Underwriters as many copies of the Prospectus (as amended or supplemented) and any Issuer Free Writing Prospectuses as the Underwriters reasonably request.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Revisions of Prospectus&#8212;Material Changes</font>. During the period in which a prospectus relating to the
          Shares is required to be delivered under the 1933 Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172),</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if (x) any event occurs or condition exists as a result of which it is necessary, in the opinion of counsel for the
          Company and of counsel for the Underwriters, to further amend or supplement the Prospectus in order that the Prospectus will not include an untrue statement of a material fact or omit to state any material fact necessary in order to make the
          statements therein not misleading, in the light of the circumstances existing at the time it is delivered to a purchaser, or (y) it is necessary, in the opinion of such counsel, to amend or supplement the Registration Statement or the Prospectus
          in order to comply with the requirements of the 1933 Act or the 1933 Act Regulations:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;prompt notice will be given, and confirmed in writing, to the Underwriters, and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="color: rgb(0, 0, 0);">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Company will promptly prepare and file an amendment or supplement to the Prospectus so that the Prospectus, as amended
          or supplemented, will (1) not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein not misleading, in the light of the circumstances existing at the time it is
          delivered to the Underwriters, or (2) comply with the requirements of the 1933 Act or the 1933 Act Regulations, as applicable, or</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; if at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development
          as a result of which (x) such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement or the Prospectus or any preliminary prospectus or (y) when considered together with the
          General Disclosure Package, included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at that
          subsequent time, not misleading, the Company will promptly notify the Underwriters and will promptly amend or supplement such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission and shall promptly
          provide such amended or supplemented Issuer Free Writing Prospectus to the Underwriters. Such notification from the Company to the Underwriters shall direct the Underwriters to suspend use of such Issuer Free Writing Prospectus until the Company
          shall have provided the Underwriters an amended or supplemented Issuer Free Writing Prospectus as contemplated above, in which case the Underwriters will cease using such Issuer Free Writing Prospectus until such time as the Company shall have
          provided them such amended or supplemented Issuer Free Writing Prospectus.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The foregoing covenants in this Section 5(e) do not apply to statements or omissions in the Prospectus or any Issuer Free Writing Prospectus made in reliance upon and in conformity with information furnished to the
          Company in writing by or on behalf of the Underwriters through the Representatives expressly for use therein.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Earnings Statements</font>. The Company will make generally available to its security holders a
          consolidated earnings statement (which need not be audited) covering a period of at least twelve months commencing after the Closing Time, as soon as is reasonably practicable after the end of such period, which earnings statement will satisfy
          the provisions of Section 11(a) of the 1933 Act (and at the option of the Company, Rule 158 of the 1933 Act Regulations).</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Blue Sky Qualifications</font>. The Company will endeavor, in cooperation with the Underwriters, to
          qualify the Shares for offering and sale under the applicable securities laws of such states and other jurisdictions as the Underwriters may reasonably designate (<font style="font-style: italic;">provided </font>that no registration will be
          required in any jurisdiction outside the United States) and will maintain such qualifications in effect for as long as may be required for the distribution of the Shares; <font style="font-style: italic;">provided, however</font>, that the
          Company will promptly notify the Underwriters of any suspension of any such qualifications; and <font style="font-style: italic;">provided, further</font>, that the Company will not be obligated to register or qualify as a foreign corporation or
          take any action which would subject it to general service of process in any jurisdiction where it is not now so subject.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Filing of Prospectus</font>. The Company will prepare and file or transmit for filing with the Commission
          within the time period specified by Rule 424(b) of the 1933 Act Regulations (without reliance on Rule 424(b)(8)), the Prospectus containing the terms of the Shares and such other information as the Representatives and the Company deem
          appropriate.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Issuer Free Writing Prospectuses</font>. (i) Each of the Company and the Selling Stockholder, severally
          and not jointly, represents and agrees that, unless it obtains the prior consent of the Representatives (which will not be unreasonably withheld or delayed), and (ii) each Underwriter, severally and not jointly, represents and agrees that, unless
          it obtains the prior written consent of the Company, the Selling Stockholder and the Representatives (which will not be unreasonably withheld or delayed), it has not made and will not make any offer relating to the Shares that would constitute an
          &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433, or that would otherwise constitute a &#8220;free writing prospectus,&#8221; as defined in Rule 405, required to be filed by the Company with the Commission or retained by the Company pursuant to Rule
          433; <font style="font-style: italic;">provided </font>that the Company and the Selling Stockholder consents to the use by any Underwriter of a free writing prospectus that:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is not an &#8220;issuer free writing prospectus&#8221; as defined in Rule 433, and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;contains only:</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;information describing the preliminary terms of the Shares or their offering, or</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;information that describes the final terms of the Shares or their offering.</div>
        <div>&#160;</div>
        <div style="text-align: justify;">Any such free writing prospectus as to which consent has been given by the Representatives or by the Company, the Selling Stockholder and the Representatives, as the case may be, is referred to as a &#8220;<font style="font-weight: bold;">Permitted Free Writing Prospectus</font>.&#8221;&#160; Without limiting the effect of the prior sentence, it is agreed that any Issuer Free Writing Prospectus listed on <u>Schedule B-2</u> is a Permitted Free Writing
          Prospectus.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Listing</font>. The Company will use its best efforts to effect and maintain the listing of the Common
          Stock on the New York Stock Exchange.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Restriction on Sale of Shares</font>. During a period of 30 days from the date of this Agreement, the
          Company will not, without the prior written consent of the Representatives, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
          right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or file any registration statement under the 1933 Act with respect to
          any of the foregoing or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of Common Stock, whether any such swap or transaction
          described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise. The foregoing sentence shall not apply to (A) the Shares to be sold hereunder, (B) any shares of Common Stock issued by
          the Company upon the exercise (whether such exercise is for cash or &#8220;cashless&#8221;), vesting or exchange of an equity award (including, without limitation, options, restricted stock units or performance stock units), warrant or other convertible,
          exercisable, exchangeable or other security outstanding on the date hereof and referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (C) any shares of Common Stock issued or any securities or other awards
          (including, without limitation, options, restricted stock units or performance stock units) to purchase Common Stock granted pursuant to existing employee benefit plans of the Company or otherwise in equity compensation arrangements referred to
          in the Registration Statement, the General Disclosure Package and the Prospectus, (D) any shares of Common Stock issued pursuant to any non-employee director stock plan or dividend reinvestment plan referred to in the Registration Statement, the
          General Disclosure Package and the Prospectus, (E) the filing by the Company of a registration statement on Form S-8 or a successor form thereto covering the registration of any shares of Common Stock or other securities issued under existing
          employee benefits plans of the Company described in the Registration Statement, the General Disclosure Package and the Prospectus, (F) any shares of Common Stock or any securities convertible into or exchangeable for, or that represent the right
          to receive, shares of Common Stock issued in connection with any bona fide licensing, commercialization, joint venture, technology transfer, acquisition, development collaboration or partnership or other strategic transaction, provided that the
          aggregate number of shares of Common Stock or securities convertible into or exercisable for Common Stock (on an as-converted or as-exercised basis, as the case may be) that the Company may sell or issue or agree to sell or issue as described in
          this clause (F) shall not exceed 5% of the total number of shares of Common Stock issued and outstanding immediately following the completion of the transactions contemplated by this Agreement or (G) as the Company may be obligated to do so
          pursuant to the Registration Rights Agreement, dated as of August 8, 2019, by and between the Company and Berkshire Hathaway Inc.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zee94af749421406c9d87ddc48fe9e97d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 6.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Payment of Expenses</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Expenses</font>. Subject to Section 6(b) of this Agreement, the Company will pay all expenses incident to
          the performance of its and the Selling Stockholder&#8217;s obligations under this Agreement, including:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The preparation and filing of the Registration Statement and all amendments thereto, the General Disclosure Package, each
          preliminary prospectus and the Prospectus and any amendments or supplements thereto and all Incorporated Documents;</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The preparation, filing and printing of this Agreement;</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; All costs and expenses related to the transfer and delivery of the Shares to the Underwriters, excluding any transfer or
          other similar taxes payable thereon by the Selling Stockholder pursuant to this Section 6;</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The costs and charges of any transfer agent, registrar or depositary;</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The qualification of the Shares under securities laws in accordance with the provisions of Section 5(g), including filing
          fees and the reasonable and documented fees and disbursements of counsel to the Underwriters in connection therewith and in connection with the preparation of any Blue Sky survey and any legal investment survey;</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The printing and delivery to the Underwriters, in quantities as hereinabove stated, of copies of the Registration
          Statement and any amendments thereto and of the General Disclosure Package, each preliminary prospectus and the Prospectus and any amendments or supplements thereto relating to the Shares, and the delivery by the Underwriters of the General
          Disclosure Package, each preliminary prospectus and the Prospectus and any amendments or supplements thereto, in each case as they relate to the Shares or to sales or solicitations of offers to purchase the Shares during the period in which a
          prospectus relating to the Shares is required to be delivered under the 1933 Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172); and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The fees and expenses incurred in connection with the listing of the Shares on the New York Stock Exchange.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Expenses of Selling Stockholder</font>. The Selling Stockholder will pay (i) any fees and expenses of
          counsel (and any other advisers) for the Selling Stockholder, (ii) any transfer or similar taxes, if any, payable upon the sale of the Shares to be sold by the Selling Stockholder to the Underwriters under the terms of the Agreement and (iii) all
          underwriting discounts, selling commissions, and fees with respect to the Shares and any other related expenses pursuant to this Agreement.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Termination of Agreement</font>. If this Agreement is terminated pursuant to any of the provisions of this
          Agreement (otherwise than by notice given by the Underwriters in connection with the occurrence of any event set forth in clauses (ii) through (iv) of Section 11(a) or pursuant to Section 12, the Company will reimburse the Underwriters for all of
          their out-of-pocket expenses, including the reasonable and documented fees and disbursements of counsel for the Underwriters, incurred in connection with this Agreement and the offering of the Shares contemplated hereby.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Allocation of Expenses</font>. The provisions of this Section 6 shall not affect any agreement that the
          Company and the Selling Stockholder may make for the sharing of such costs and expenses.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" id="z7f34f750422948dd8ebf45d771be70b4">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 7.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Conditions of Underwriters&#8217; Obligations</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The obligations of the Underwriters hereunder are subject to the accuracy of the representations and warranties on the part of the Company and the Selling Stockholder herein and the accuracy of the statements of the
          Company&#8217;s and the Selling Stockholder&#8217;s officers made in any certificate furnished pursuant to the provisions of this Agreement, to the performance and observance by the Company and the Selling Stockholder of all covenants and agreements herein
          contained on its part to be performed and observed and to the following additional conditions precedent:</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);"> <br>
          </font></div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Registration Statement and Prospectus</font>. The Registration Statement and any post-effective amendments
          thereto will have become effective under the 1933 Act and at the Closing Time, no stop order suspending the effectiveness of the Registration Statement will have been issued and no proceedings for that purpose will be instituted, or to the
          knowledge of the Company or the Underwriters, will have been threatened by the Commission; and no stop order suspending the sale of the Shares in any jurisdiction designated by the Underwriters pursuant to Section 5(g) of this Agreement will have
          been issued and no proceedings for that purpose will have been instituted, or to the knowledge of the Company or the Underwriters, will have been threatened. The Prospectus referred to in Section 5(h) of this Agreement will have been transmitted
          to the Commission for filing pursuant to Rule 433 and Rule 424(b) (without reliance on Rule 424(b)(8)), respectively, of the 1933 Act Regulations within the prescribed time period, and prior to Closing Time the Company will have provided evidence
          satisfactory to the Underwriters of such timely filing, and all requests of the Representatives for additional information will have been complied with to the reasonable satisfaction of the Representatives.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Opinion of Company Counsel</font>. The Underwriters will have received (i) an opinion from the Deputy
          General Counsel for the Company, dated as of the Closing Time and in form and substance satisfactory to counsel for the Underwriters (and including customary qualifications, assumptions and limitations), and (ii) an opinion from Cravath, Swaine
          &amp; Moore LLP, dated as of the Closing Time and in form and substance satisfactory to counsel for the Underwriters (and including customary qualifications, assumptions and limitations).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Opinion of Selling Stockholder&#8217;s Counsel</font>. The Underwriters will have received an opinion from
          Vinson &amp; Elkins LLP, dated as of the Closing Time and in form and substance satisfactory to counsel for the Underwriters (and including customary qualifications, assumptions and limitations).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Opinion of Underwriters&#8217; Counsel</font>. The Underwriters will have received an opinion from Weil, Gotshal
          &amp; Manges LLP, counsel to the Underwriters, dated as of the Closing Time and in form and substance satisfactory to the Representatives.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Officer&#8217;s Certificate of the Company</font>.&#160; Except as contemplated in the Prospectus and the General
          Disclosure Package or reflected therein by the filing of any amendment or supplement thereto or any Incorporated Document, at the Closing Time, there will not have been, since the date of the most recent consolidated financial statements included
          or incorporated by reference in the Prospectus or the General Disclosure Package, any material adverse change, or any development that is reasonably likely to result in a material adverse change, in the consolidated financial condition or
          consolidated results of operations of the Company and its subsidiaries, taken as a whole. The Underwriters will have received a certificate signed by an officer of the Company, dated as of the Closing Time, to the effect that, solely in his or
          her capacity as an officer of the Company, on behalf of the Company: (i) there has been no such material adverse change, (ii) the representations and warranties of the Company contained in Section 1 (other than Section 1(j)) are true and correct
          with the same force and effect as though expressly made at and as of the date of such certificate, (iii) that the Company has complied with all agreements and satisfied all conditions required by this Agreement on its part to be performed or
          satisfied at or prior to the date of such certificate and (iv) (x) no stop order suspending the effectiveness of the Registration Statement has been issued under the 1933 Act, (y) to the knowledge of such officer, the Registration Statement is
          not the subject of a pending proceeding or examination under Section 8(d) or 8(e) of the 1933 Act and the Company is not the subject of a pending proceeding under Section 8A of the 1933 Act in connection with the offering of the Shares and (z) to
          the knowledge of such officer, no proceedings for any of the foregoing purposes have been instituted or are pending or are threatened by the Commission.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Officer&#8217;s Certificate of the Selling Stockholder. </font>The Underwriters will have received a certificate
          signed by or on behalf of the Selling Stockholder, dated as of the Closing Time, to the effect that (i) the representations and warranties of the Selling Stockholder contained in Section 2 are true and correct with the same force and effect as
          though expressly made at and as of the date of such certificate and (ii) the Selling Stockholder has complied with all agreements and satisfied all conditions required by this Agreement on its part to be performed or satisfied at or prior to the
          date of such certificate.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Comfort Letter</font>. On the date of this Agreement, the Underwriters will have received a letter from
          the Company&#8217;s independent registered public accounting firm and OxyRock&#8217;s independent certified public accounting firm, each dated as of the date of this Agreement and in form and substance satisfactory to the Representatives, containing
          statements and information of a type ordinarily included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements and certain financial information contained or incorporated by reference in the Registration
          Statement, the General Disclosure Package and the Prospectus; and, if financial statements for any assets, business or entity acquired by the Company or by OxyRock, as applicable, are included or incorporated by reference in the Registration
          Statement, the General Disclosure Package or the Prospectus, the Underwriters will have received a similar &#8220;comfort letter&#8221; from an independent registered or certified public accounting firm, as applicable, dated as of the date of this Agreement
          and in form and substance satisfactory to the Representatives, with respect to such financial statements and any financial information with respect to such assets, business or entity, as the case may be, contained or incorporated by reference in
          the Registration Statement, the General Disclosure Package and the Prospectus.</div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">
          <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Subsequent Delivery of Comfort Letter</font>. At the Closing Time, the Underwriters will have received from each independent
            registered or certified public accounting firm, as applicable, which delivered a letter pursuant to subsection 7(g), a letter, dated as of the Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant
            to subsection 7(g), except that the specified date referred to will be a date not more than three days prior to the Closing Time.</div>
          <div>&#160;</div>
          <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Reserve Letter</font>. On the date of this Agreement, the Underwriters will have received a letter from the Company&#8217;s
            independent petroleum consultant and OxyRock&#8217;s independent petroleum consultant, each dated as of the date of this Agreement and each in form and substance satisfactory to the Representatives, with respect to the reserve information of the
            Company and OxyRock, as applicable, contained or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus.</div>
        </div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Subsequent Delivery of Reserve Letter</font>. At the Closing Time, the Underwriters will have received
          from each independent petroleum consultant which delivered a letter pursuant to subsection 7(i), a letter, dated as of the Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection 7(i).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Lock-Up Agreements.</font> At the date of this Agreement, the Representatives shall have received an
          agreement substantially in the form of <u>Exhibit A</u> hereto signed by the Selling Stockholder and the other persons listed on <u>Schedule D</u> hereto.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Other Documents</font>. At the Closing Time, counsel for the Underwriters will have been furnished with
          such documents as such counsel may reasonably require for the purpose of enabling such counsel to pass upon the issuance and sale of the Shares as herein contemplated and supporting proceedings, or in order to evidence the accuracy and
          completeness of any of the representations and warranties, or the fulfillment of any of the conditions, contained in this Agreement.</div>
        <div>&#160;</div>
        <div style="text-indent: 27pt;">&#160;&#160; If any condition specified in this Section 7 remains unfulfilled when and as required to be fulfilled, this Agreement may be terminated by the Representatives by notice to the Company and the Selling Stockholder
          at any time at or prior to the Closing Time, and any such termination will be without liability of any party to any other party, except that the acknowledgements and agreements in Section 3(c), the provisions of Section 6, the indemnity and
          contribution agreements set forth in Sections 8 and 9 and the provisions of Section 16 will remain in effect.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z509e2537893e457e9551afdc36e66b44" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 8.</td>
              <td style="vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Indemnification</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Indemnification of the Underwriters by the Company</font>. The Company agrees to indemnify and hold
          harmless each Underwriter, each officer and director<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>of each Underwriter and each person, if any, who controls an Underwriter within the meaning of Section 15 of the
          1933 Act as follows:</div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; against any and all loss, liability, claim, damage and expense whatsoever (including, subject to the limitations set forth
          in subsection 8(d), the reasonable and documented fees and disbursements of counsel chosen by the Representatives), as incurred, insofar as such loss, liability, claim, damage or expense arises out of or is based upon any untrue statement or
          alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements
          therein not misleading, or arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus, the General Disclosure Package, any Issuer Free Writing Prospectus or the
          Prospectus (or any amendment or supplement thereto) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; against any and all loss, liability, claim, damage and expense whatsoever (including, subject to the limitations set forth
          in subsection 8(d), the reasonable and documented fees and disbursements of counsel chosen by the Representatives), as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or investigation or proceeding by any
          governmental agency or body, commenced or threatened, or of any claim whatsoever, insofar as such loss, liability, claim, damage or expense arises out of or is based upon any such untrue statement or omission, or any such alleged untrue statement
          or omission, if such settlement is effected with the written consent of the Company; and</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; against any and all expense whatsoever (including, subject to the limitations set forth in subsection 8(d), the
          reasonable and documented fees and disbursements of counsel chosen by the Representatives), as incurred, reasonably incurred in investigating, preparing or defending against any litigation, or investigation or proceeding by any governmental
          agency or body, commenced or threatened, or any claim whatsoever, based upon any such untrue statement or omission, or any such alleged untrue statement or omission;</div>
        <div>&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">, <font style="font-style: italic;">however</font>, that this indemnity will not apply to any loss, liability, claim, damage or expense as to which such Underwriter may be required to indemnify the Company pursuant to the provisions of
            subsection (c) of this Section 8 or as to which the Selling Stockholder may be required to indemnify the Underwriters and/or the Company pursuant to the provisions of subsection (b) of this Section 8.</font></div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Indemnification of Underwriters and the Company by Selling Stockholder</font>. The Selling Stockholder
          agrees to indemnify and hold harmless each Underwriter, each officer and director of each Underwriter and each person, if any, who controls an Underwriter within the meaning of Section 15 of the 1933 Act, and the Company, its directors, each of
          its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act, in each case to the extent and in the manner set forth in clauses (a)(i), (ii) and (iii) above;
          <font style="font-style: italic;">provided </font>that the Selling Stockholder shall be liable only to the extent that such untrue statement or alleged untrue statement or omission or alleged omission has been made in the Registration Statement,
          any preliminary prospectus, the General Disclosure Package, the Prospectus (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus in reliance upon and in conformity with the Selling Stockholder Information; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">further</font>, that the liability under this subsection of the Selling Stockholder shall be limited to an amount equal to the aggregate gross proceeds after
          underwriting commissions and discounts to the Selling Stockholder from the sale of Shares sold by the Selling Stockholder hereunder.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Indemnification of the Company and Selling Stockholder</font>. Each Underwriter agrees, severally and not
          jointly, to indemnify and hold harmless the Company, its directors, each of its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act, and the Selling
          Stockholder and each person, if any, who controls the Selling Stockholder within the meaning of Section 15 of the 1933 Act against any and all loss, liability, claim, damage and expense described in the indemnity contained in subsection 8(a), as
          incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement, any preliminary prospectus, the General Disclosure Package, any Issuer Free Writing Prospectus or
          the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Underwriter through the Representatives expressly for use in the Registration
          Statement, such preliminary prospectus, the General Disclosure Package, such Issuer Free Writing Prospectus or the Prospectus (or such amendment or supplement). The Company hereby acknowledges that the only information that the Underwriters have
          furnished to the Company by or on behalf of such Underwriter through the Representatives expressly for use in the Registration Statement, such preliminary prospectus, the General Disclosure Package, such Issuer Free Writing Prospectus or the
          Prospectus (or any amendment or supplement thereto) are: (i) the information in the thirteenth paragraph and the fourteenth paragraph under the caption &#8220;Underwriting&#8221; in the preliminary prospectus supplement and the Final Prospectus Supplement,
          but solely insofar as it concerns stabilization transactions by the Underwriters; and (ii) the information in the first sentence of the sixteenth paragraph under the caption &#8220;Underwriting&#8221; in the preliminary prospectus supplement and the Final
          Prospectus Supplement, but solely insofar as it concerns market making by the Underwriters.</div>
        <div style="text-align: justify; text-indent: 36pt;"> <br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">General</font>. (i) In case any action, suit or proceeding (including any governmental or regulatory
          investigation or proceeding) is brought against any indemnified party, based upon the Registration Statement, any preliminary prospectus, the General Disclosure Package, any Issuer Free Writing Prospectus or the Prospectus (or any amendment or
          supplement thereto) and with respect to which indemnity may be sought against an indemnifying party pursuant to this Section 8, such indemnified party will promptly notify such indemnifying party in writing, and the indemnifying party will assume
          the defense thereof, including the employment of counsel reasonably satisfactory to the indemnified party and payment of all expenses. Failure to give such notice will not relieve the indemnifying party from any liability under this Section 8 to
          the extent it is not materially prejudiced as a result thereof and in any event will not relieve it from any liability which it may have otherwise than on account of the indemnity contained in this Section 8. Any such indemnified party will have
          the right to employ separate counsel in any such action, suit or proceeding and to participate in the defense thereof, but the fees and expenses of such separate counsel will be at the expense of such indemnified party, unless (A) the employment
          of such counsel has been specifically authorized in writing by the indemnifying party (notwithstanding the foregoing, if the indemnifying party is the Underwriters or such officers, directors or such controlling persons thereof, any authorization
          under this clause (A) will be provided by the Representatives, on behalf of all of such Underwriters, all such officers and directors and such controlling persons and copies of all such notices given by the indemnified person will also be sent to
          the Representatives), (B) the indemnifying party has failed to assume the defense and employ reasonably satisfactory counsel or (C) the named parties to any such action, suit or proceeding (including any impleaded parties) include such
          indemnified party and the indemnifying party, and such indemnified party has been advised by such counsel that there may be one or more legal defenses available to it that are different from, or additional to, those available to the indemnifying
          party (in which case, if such indemnified party notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party will not have the right to assume the defense of
          such action, suit or proceeding on behalf of such indemnified party, it being understood, however, that the indemnifying party will not, in connection with any one such action or separate but substantially similar or related actions in the same
          jurisdiction arising out of the same general allegations or circumstances, be liable for the fees and expenses of more than one separate firm of attorneys (in addition to one separate firm of attorneys acting as local counsel in each relevant
          jurisdiction) for all such indemnified parties, which firm will be designated in writing by the indemnified parties (and in the case of the Underwriters or such officers and directors and such controlling persons thereof, by the Representatives,
          on behalf of all of such Underwriters, all such officers and directors and such controlling persons). An indemnifying party will not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of
          any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such
          claim or action) unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and (ii) does not include a statement as to or
          an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Other Agreements with Respect to Indemnification</font>. The provisions of this Section 8 shall not affect
          any agreement among the Company and the Selling Stockholder with respect to indemnification.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z67a153d83feb4b649dd41e2f70f035a8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 9.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Contribution</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">In order to provide for just and equitable contribution in circumstances in which the indemnity agreement provided for in Section 8 is for any reason held to be unenforceable with respect to the indemnified parties,
          although applicable in accordance with its terms, each indemnifying party will contribute to the aggregate losses, liabilities, claims, damages and expenses of the nature contemplated by said indemnity agreement incurred by the indemnified party,
          as incurred, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company and the Selling Stockholder, on the one hand, and the Underwriters, on the other hand, from the offering of the Shares or (ii) if the
          allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company and the Selling
          Stockholder, on the one hand, and of the Underwriters, on the other hand, in connection with the statements or omissions that resulted in such losses, liabilities, claims, damages and expenses. The relative benefits received by the Company and
          the Selling Stockholder, on the one hand, and the Underwriters, on the other hand, will be deemed to be in the same respective proportions as the total net proceeds from the sale of the Shares (before deducting expenses) received by the Selling
          Stockholder, on the one hand, and the total underwriting discounts and commissions received by the Underwriters, on the other hand, bear to the total price to public of the Shares as set forth in the table on the cover page of the Prospectus. The
          relative fault of the Company and the Selling Stockholder, on the one hand, and the Underwriters, on the other hand, will be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the
          omission or alleged omission to state a material fact relates to information supplied by the Company or the Selling Stockholder or by the Underwriters and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct
          or prevent such statement or omission. The Underwriters&#8217; respective obligations to contribute pursuant to this Section 9 are several in proportion to the respective number of Shares set forth opposite their names in <u>Schedule A</u>, and not
          joint. Notwithstanding the provisions of this Section 9, no Underwriter will be required to contribute any amount in excess of the amount by which the total price at which the Shares underwritten by it and distributed by the public were offered
          to the public exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission, and the Selling Stockholder shall not be required to
          contribute any amount in excess of the aggregate gross proceeds after underwriting commissions and discounts, but before expenses, received by the Selling Stockholder. No person guilty of fraudulent misrepresentation (within the meaning of
          Section 11(f) of the 1933 Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 9, each officer and director of an Underwriter and each person, if any, who
          controls an Underwriter within the meaning of Section 15 of the 1933 Act will have the same rights to contribution as such Underwriter, and each director of the Company, each officer of the Company who signed the Registration Statement and each
          person, if any, who controls the Company or the Selling Stockholder within the meaning of Section 15 of the 1933 Act will have the same rights to contribution as the Company or the Selling Stockholder, as the case may be. Any party entitled to
          contribution hereunder will, promptly after receipt of notice of commencement of any action, suit or proceeding against such party in respect of which a claim for contribution may be made against another party or parties under this Section 9,
          notify such party or parties from whom contribution may be sought (with, in the case of any notice given by the Company or the Selling Stockholder or any of their respective officers, directors or controlling persons, a copy to the
          Representatives), but the omission to so notify such party or parties will not relieve the party or parties from whom contribution may be sought from any obligation under this Section 9 to the extent it or they are not materially prejudiced as a
          result thereof and in any event will not relieve it or them from any other obligation it or they may have otherwise than under this Section 9. The provisions of this Section shall not affect any agreement among the Company and the Selling
          Stockholder with respect to contribution.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z14cc7390701d4e8b902bcdd001b7f5d0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 10.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Representations, Warranties and Agreements to Survive Delivery</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">All representations, warranties and agreements contained in this Agreement (including, without limitation, the provisions of Sections 8 and 9), or contained in certificates signed by any officer of the Company or the
          Selling Stockholder and delivered to the Underwriters, the Representatives or counsel for the Underwriters in connection with the transactions contemplated in this Agreement, will remain operative and in full force and effect, regardless of any
          investigation made by or on behalf of any Underwriter, any officer or director of any Underwriter or any controlling person of any Underwriter, or by or on behalf of the Company or the Selling Stockholder, and will survive delivery of and payment
          for any of the Shares.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="ze94b0de0d3e44cd988b6d4f873053797" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 11.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Termination</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Representatives may terminate this Agreement, by notice to the Company and the Selling Stockholder, at any time at or prior to the
          Closing Time if between the date of this Agreement and the Closing Time:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; there has been any material adverse change in the consolidated financial condition of the Company and its subsidiaries,
          taken as a whole,</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; there has occurred any material adverse change in the financial markets in the United States or any outbreak or
          escalation of hostilities or other national or international calamity or crisis, in each case set forth in this clause (ii) the effect of which, individually or in the aggregate, shall be such as to make it, in the reasonable judgment of the
          Representatives, impracticable to proceed with the offering, sale or delivery of the Shares or to enforce contracts for sale of the Shares,</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%27%%%-->
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; trading in any securities of the Company has been suspended by the Commission or a national securities exchange in the
          United States, or if trading generally on the New York Stock Exchange has been suspended or settlement has been materially disrupted, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices for securities have been
          required, by said exchange or by order of the Commission or any other governmental authority, or if a banking moratorium has been declared by either Federal or New York authorities, or</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160; any of S&amp;P Global Ratings and Moody&#8217;s Investors Service, Inc. (or any of their respective successors) has publicly
          announced that it has (A) placed the Company&#8217;s unsecured senior long term debt on what is commonly termed a &#8220;watch list&#8221; for possible downgrading or (B) downgraded the Company&#8217;s unsecured senior long term debt generally.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If this Agreement is terminated pursuant to this Section, the provisions of Section 6(c), Section 8, Section 9 and Section 16 shall survive
          such termination.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z42d1b400f4b54e1fb769b704b897813f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 12.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Default by One or More of the Underwriters</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">If one or more of the Underwriters fails at the Closing Time to purchase the Shares which it or they are obligated to purchase under this Agreement (the &#8220;<font style="font-weight: bold;">Defaulted Shares</font>&#8221;),
          the non-defaulting Underwriters will have the right, within 24 hours thereafter, to make arrangements for one or more of such non-defaulting Underwriters, or any other underwriters, to purchase all, but not less than all, of the Defaulted Shares
          in such amounts as may be agreed upon and upon the terms herein set forth; <font style="font-style: italic;">provided, however</font>, that if such non-defaulting Underwriters have not completed such arrangements within such 24-hour period,
          then:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the number of Defaulted Shares does not exceed 10% of the total number of Shares, the non-defaulting Underwriters will be obligated,
          severally and not jointly, to purchase the full amount thereof in the proportions that their respective underwriting obligations hereunder bear to the underwriting obligations of all non-defaulting Underwriters, or</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the number of Defaulted Shares exceeds 10% of the total number of Shares, this Agreement will terminate without liability on the part of
          any non-defaulting Underwriter or the Company, except that the acknowledgements and agreements in Section 3(c), the provisions of Section 6, and the indemnity and contribution agreements set forth in Sections 8 and 9 and the provisions of Section
          16 will remain in effect.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">No action pursuant to this Section will relieve any defaulting Underwriter from liability in respect of its default.</div>
        <div style="text-indent: 36pt;">&#160;</div>
        <div style="text-indent: 36pt;">In the event of any such default which does not result in a termination of this Agreement, either (i) the Representatives or (ii) the Company and the Selling Stockholder will have the right to postpone the Closing
          Time for a period not exceeding seven days in order to effect any required changes in the Registration Statement or Prospectus or in any other documents or arrangements. The term &#8220;<font style="font-weight: bold;">Underwriter</font>&#8221; as used in
          this Agreement will include any underwriter substituted for a defaulting Underwriter.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%28%%%-->
        <table cellspacing="0" cellpadding="0" id="zd16d0a7b606a4dbfb9b81c5a7cffb5c8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 13.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Notices</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">All notices and other communications under this Agreement must be in writing and will be deemed to have been duly given if mailed or transmitted by any standard form of telecommunication. Notices to the Underwriters
          and the Representatives must be directed to them at J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Equity Syndicate Desk, Facsimile: (212) 622-8358; Morgan Stanley &amp; Co. LLC, Attention: Equity Syndicate
          Desk (copy to Legal Department), 1585 Broadway, New York, New York 10036; RBC Capital Markets, LLC, Attention: Equity Capital Markets, Three World Financial Center, 200 Vesey Street, New York, NY 10281. Notices to the Company must be directed to
          it at 5 Greenway Plaza, Suite 110, Houston, Texas 77046, Attention: Vice President and Treasurer (email: <u>TreasuryFinance@oxy.com</u>). Notices to the Selling Stockholder must be directed to them at 18 Desta Dr., Midland, Texas 79705,
          Attention: Lee Dunn (email: lee.dunn@crownquest.com).</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z93425a1b31a44821af7fc52833c01bb4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 14.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Parties</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">This Agreement will inure to the benefit of and be binding upon the Underwriters, the Company, the Selling Stockholder and their respective successors. Nothing expressed or mentioned in this Agreement is intended or
          will be construed to give any person, firm or corporation, other than the parties hereto and their respective successors and the officers, directors and controlling persons referred to in Sections 8 and 9 and their heirs and legal
          representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provisions herein contained. This Agreement and all conditions and provisions of this Agreement are intended to be for the sole and
          exclusive benefit of the parties hereto and their respective successors and said officers, directors and controlling persons and their heirs and legal representatives, and for the benefit of no other person, firm or corporation. No purchaser of
          Shares will be deemed to be a successor by reason merely of such purchase.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z8cf78b3e34fa4a8c875ff9039330e0ba" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 15.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Recognition of the U.S. Special Resolution Regimes</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the
          transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and
          any such interest and obligation, were governed by the laws of the United States or a state of the United States.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
          a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution
          Regime if this Agreement were governed by the laws of the United States or a state of the United States.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The terms which follow, when used in this Section 15, shall have the meanings indicated:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">BHC Act Affiliate</font>&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167;
          1841(k).</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Covered Entity</font>&#8221; means any of the following:</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or</div>
        <div>&#160;</div>
        <div style="text-align: justify; margin-right: 18pt; margin-left: 108pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Default Right</font>&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or
          382.1, as applicable.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">U.S. Special Resolution Regime</font>&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)
          Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z187c1d652abe44c8bbb7953eac9cedd1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 16.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Governing Law</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">This Agreement and the rights and obligations of the parties created hereby will be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and to be performed in
          such State, including, without limitation, Section 5-1401 of the New York General Obligations Law.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z6deb65eb86f64ebd858916da52b93155" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 17.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">[Reserved]</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zd074d428478e4416b21591f1c9091cb5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 18.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Counterparts</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">This Agreement may be signed in one or more counterparts, each of which shall constitute an original and all of which together shall constitute one and the same agreement. The words &#8220;execution,&#8221; &#8220;signed,&#8221;
          &#8220;signature,&#8221; &#8220;delivery&#8221; and words of like import in or relating to this Agreement or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic
          form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to
          conduct the transactions contemplated hereunder by electronic means.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zeca6896624ab41799586080f54d0f75d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0);">SECTION 19.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">USA PATRIOT Act</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">.</font></div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">In accordance with the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law on October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies
          their respective clients, including the Company, which information may include the name and addresses of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients.</div>
        <div>&#160;</div>
        <div style="text-align: center;">[Signature Pages Follow]</div>
        <div style="text-align: center;"> <br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-indent: 36pt;">If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company a counterpart of this Agreement, whereupon this instrument along with all counterparts will become a
          binding agreement among the Underwriters, the Selling Stockholder and the Company in accordance with its terms.</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" id="z58fc7cf903324c7c84210cd4c9c0b0b1" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-indent: 36pt;">&#160;&#160;&#160; <br>
                </div>
              </td>
              <td style="vertical-align: top;" colspan="2">
                <div>Very truly yours,</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="vertical-align: top;" colspan="2">
                <div style="font-weight: bold;">THE COMPANY:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="vertical-align: top;" colspan="2">
                <div>OCCIDENTAL PETROLEUM CORPORATION</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0);">By:</div>
              </td>
              <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); width: 47%;">/s/ Jaime R. Casas<br>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div style="color: rgb(0, 0, 0);">Name: Jaime R. Casas<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div style="color: rgb(0, 0, 0);">Title: Vice President and Treasurer<br>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" id="zf4f14e301a234715a7ae060c568b0928" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
                </div>
              </td>
              <td style="vertical-align: top;" colspan="2">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">THE SELLING STOCKHOLDER:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="vertical-align: top;" colspan="2">
                <div>CROWNROCK HOLDINGS, L.P.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 3%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 3%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">By:</div>
              </td>
              <td rowspan="1" style="width: 47%; vertical-align: top;">CrownRock Holdings GP, LLC, its general partner<br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td rowspan="1" style="width: 47%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0);">By:</div>
              </td>
              <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Timothy M. Dunn<br>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div style="color: rgb(0, 0, 0);">Name: Timothy M. Dunn<br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div style="color: rgb(0, 0, 0);">Title: Chief Executive Officer<br>
                </div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">[Signature Page to Underwriting Agreement]</div>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;"> <br>
          </div>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        CONFIRMED AND ACCEPTED, as of the date first above written:
        <div>&#160; <br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" id="z5472f22074964fd490b9b1fc4b43b589" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td rowspan="1" style="width: 3%; vertical-align: top;">By:</td>
              <td rowspan="1" style="vertical-align: top; width: 47%;">
                <div>J.P. MORGAN SECURITIES LLC</div>
              </td>
              <td rowspan="1" style="vertical-align: top; width: 50%;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 3%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="vertical-align: top; width: 47%;">&#160;</td>
              <td rowspan="1" style="vertical-align: top; width: 50%;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div><font style="color: rgb(0, 0, 0);">By:</font> </div>
              </td>
              <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); width: 47%;">/s/ Lucy Brash<br>
              </td>
              <td style="vertical-align: top; width: 50%; padding-bottom: 2px;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div style="color: rgb(0, 0, 0);">Name: Lucy Brash<br>
                </div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div style="color: rgb(0, 0, 0);">Title: Managing Director<br>
                </div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div>For themselves and as Representatives of the Underwriters named in <u>Schedule A</u>.</div>
        <div>&#160;</div>
        <div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">[Signature Page to Underwriting Agreement]</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;"> <br>
          </div>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-indent: -22.3pt; margin-left: 22.3pt;">CONFIRMED AND ACCEPTED, as of the date first above written:</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" id="ze412b23110fd46fab768819b904b158d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 3%; vertical-align: top;" rowspan="1">By:</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div>MORGAN STANLEY &amp; CO. LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;"><br>
              </td>
              <td style="width: 47%; vertical-align: top;"><br>
              </td>
              <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0);">By:</div>
              </td>
              <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Daniel J.F. McCullough<br>
              </td>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div style="color: rgb(0, 0, 0);">Name: Daniel J.F. McCullough<br>
                </div>
              </td>
              <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div style="color: rgb(0, 0, 0);">Title: Executive Director<br>
                </div>
              </td>
              <td style="width: 50%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div>For themselves and as Representatives of the Underwriters named in <u>Schedule A</u>.</div>
        <div>&#160;</div>
        <div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">[Signature Page to Underwriting Agreement]</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;"> <br>
          </div>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-indent: -22.3pt; margin-left: 22.3pt;">CONFIRMED AND ACCEPTED, as of the date first above written:</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" id="z70f13c1cba564cf3b77b69afd807763b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 3%; vertical-align: top;" rowspan="1">By:</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">
                <div>RBC CAPITAL MARKETS, LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 47%; vertical-align: top;" rowspan="1">&#160;</td>
              <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top; padding-bottom: 2px;" rowspan="1"><font style="color: rgb(0, 0, 0);">By:</font></td>
              <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">/s/ Young Kim<br>
              </td>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Name: Young Kim<br>
                </div>
              </td>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 3%; vertical-align: top;">&#160;</td>
              <td style="width: 47%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Title: Managing Director<br>
                </div>
              </td>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div>For themselves and as Representatives of the Underwriters named in <u>Schedule A</u>.</div>
        <div>&#160;</div>
        <div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">[Signature Page to Underwriting Agreement]</div>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;"> <br>
          </div>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%Sch. A-%%-->
        <div>
          <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">SCHEDULE A</div>
        </div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z6ccf1f90a7f64de6951e6ab711a88ab2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

            <tr>
              <td rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); width: 77%;">
                <div><font style="font-weight: bold;"> <br>
                  </font></div>
                <div><font style="font-weight: bold;">Underwriter</font></div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
              <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold; text-align: center;">Number of Shares to </div>
                <div style="font-weight: bold; text-align: center;">be Purchased</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 77%; background-color: rgb(204, 238, 255);">
                <div>J.P. Morgan Securities LLC</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 20%; background-color: rgb(204, 238, 255);">
                <div>9,853,540</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 77%;">
                <div>Morgan Stanley &amp; Co. LLC</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 20%;">
                <div>9,853,540</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 77%; background-color: rgb(204, 238, 255);">
                <div>RBC Capital Markets, LLC</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 20%; background-color: rgb(204, 238, 255);">
                <div>9,853,539</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 77%;">
                <div style="font-weight: bold; margin-left: 9pt;">Total</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 20%;">
                <div>29,560,619</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">Sch. A-1</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%Sch. B-%%-->
        <div style="text-align: center; font-weight: bold;">
          <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">SCHEDULE B-1</div>
        </div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-weight: bold;">Pricing Terms</div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" id="z96ae9f0bf80c40dfa36f294ab24c9127" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 36pt; vertical-align: top;">1.</td>
                <td style="vertical-align: top;">
                  <div>The Selling Stockholder is selling 29,560,619 shares of Common Stock.</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" id="zac1b33b1715549fa87b8881339534f3d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 36pt; vertical-align: top; text-align: right;">
                  <div style="text-align: left;">2.&#160; <br>
                  </div>
                </td>
                <td style="width: auto; vertical-align: top;">
                  <div>The public offering price per share for the Shares shall be variable.</div>
                </td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">Sch. B-1</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%Sch. B-%%-->
        <div style="text-align: center; font-weight: bold;">
          <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">SCHEDULE B-2</div>
        </div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-weight: bold;">Issuer General Use Free Writing Prospectuses</div>
        <div><br>
        </div>
        <div>None.</div>
        <div> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">Sch. B-2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%Sch. C-%%-->
        <div style="text-align: center; font-weight: bold;">
          <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">SCHEDULE C</div>
        </div>
        <div style="text-align: center; font-weight: bold;">Selling Stockholder</div>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z9e21793993064c56ae2a5635dc41d305" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

            <tr>
              <td valign="bottom" style="vertical-align: top;">
                <div><u> <br>
                  </u></div>
                <div><u>Selling Stockholder</u></div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
              <td valign="bottom" colspan="2" style="vertical-align: top;">
                <div style="text-align: center;">Number of<u> </u></div>
                <div style="text-align: center;"><u>Shares</u>:</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 88%; background-color: rgb(204, 238, 255);">
                <div>CrownRock Holdings, L.P.</div>
              </td>
              <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div>29,560,619</div>
              </td>
              <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">Sch. C-1</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%Sch. D-%%-->
        <div style="text-align: center; font-weight: bold;">
          <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">SCHEDULE D</div>
        </div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-weight: bold;">List of Persons and Entities Subject to Lock-up</div>
        <div>&#160;</div>
        <div><u>Directors</u></div>
        <div>&#160;</div>
        <div>Vicky A. Bailey</div>
        <div>Andrew F. Gould</div>
        <div>Carlos M. Gutierrez</div>
        <div>Vicki Hollub</div>
        <div>William R. Klesse</div>
        <div>Jack B. Moore</div>
        <div>Claire O&#8217;Neill</div>
        <div>Avedick B. Poladian</div>
        <div>Kenneth B. Robinson</div>
        <div>Robert M. Shearer</div>
        <div><br>
        </div>
        <div><u>Officers</u></div>
        <div>&#160;</div>
        <div>Peter J. Bennett</div>
        <div>Christopher O. Champion</div>
        <div>Kenneth Dillon</div>
        <div>Vicki Hollub</div>
        <div>Richard A. Jackson</div>
        <div>Sylvia J. Kerrigan</div>
        <div>Sunil Matthew</div>
        <div>Robert L. Peterson</div>
        <div>Jeff F. Simmons</div>
        <div><br>
        </div>
        <div><u>Selling Stockholder</u></div>
        <div>&#160;</div>
        <div>CrownRock Holdings, L.P.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">Sch. D-1</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%A-%%-->
        <div style="text-align: center; font-weight: bold;">
          <div style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">EXHIBIT A</div>
        </div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-weight: bold;">FORM OF LOCK-UP AGREEMENT</div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-weight: bold;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;" id="z9c9bd2740f6247e3a0eef567e7e67d30">

              <tr>
                <td style="width: 40%; padding-bottom: 2px;" colspan="1" rowspan="1">&#160;</td>
                <td style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
                <td style="width: 50%; padding-bottom: 2px;" rowspan="1">&#160;, 2024</td>
              </tr>

          </table>
        </div>
        <div>&#160;</div>
        <div>J.P. Morgan Securities LLC</div>
        <div>Morgan Stanley &amp; Co. LLC</div>
        <div>RBC Capital Markets, LLC</div>
        <div style="text-indent: -18pt; margin-left: 18pt;">As representatives of the several Underwriters</div>
        <div>&#160;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">c/o J.P. Morgan Securities LLC</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">383 Madison Avenue</div>
        <div style="text-align: justify; color: rgb(0, 0, 0);">New York, New York 10179</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">c/o Morgan Stanley &amp; Co. LLC</div>
        <div style="color: rgb(0, 0, 0);">1585 Broadway</div>
        <div style="color: rgb(0, 0, 0);">New York, New York 10036</div>
        <div><br>
        </div>
        <div style="color: rgb(0, 0, 0);">c/o RBC Capital Markets, LLC</div>
        <div style="color: rgb(0, 0, 0);">Three World Financial Center</div>
        <div style="color: rgb(0, 0, 0);">200 Vesey Street</div>
        <div style="color: rgb(0, 0, 0);">New York, New York 10281-8098</div>
        <div><br>
        </div>
        <div>Ladies and Gentlemen:</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">The undersigned understands that J.P. Morgan Securities LLC, Morgan Stanley &amp; Co. LLC and RBC Capital Markets, LLC (the &#8220;<font style="font-weight: bold;">Representatives</font>&#8221;) propose to
          enter into an Underwriting Agreement (the &#8220;<font style="font-weight: bold;">Underwriting Agreement</font>&#8221;) with Occidental Petroleum Corporation, a Delaware corporation (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) and CrownRock
          Holdings, L.P. (the &#8220;<font style="font-weight: bold;">Selling Stockholder</font>&#8221;) providing for the public offering (the &#8220;<font style="font-weight: bold;">Public Offering</font>&#8221;) by the several Underwriters, including the Representatives (the &#8220;<font style="font-weight: bold;">Underwriters</font>&#8221;), of 29,560,619 shares (the &#8220;<font style="font-weight: bold;">Shares</font>&#8221;) of the common stock, par value $0.20 per share, of the Company (the &#8220;<font style="font-weight: bold;">Common Stock</font>&#8221;)




          pursuant to a Registration Statement on Form S-3 filed with the U.S. Securities and Exchange Commission on August 2, 2024 (the &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221;). Certain capitalized terms used but not otherwise
          defined herein shall have the respective meanings ascribed to such terms in the Underwriting Agreement. To the extent there are no additional Underwriters named in Schedule A to the Underwriting Agreement other than you, the terms Representatives
          and Underwriters as used herein shall mean you, as Underwriter, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">A-1</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%A-%%-->
        <div style="text-align: justify; text-indent: 36pt;">To induce the Underwriters that may participate in the Public Offering to continue their efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior
          written consent of the Representatives on behalf of the Underwriters, he, she or it will not, and will not cause any direct or indirect affiliate to, and will not publicly disclose an intention to, during the period commencing on the date hereof
          and ending 30 days after the date of the Underwriting Agreement (the &#8220;<font style="font-weight: bold;">Restricted Period</font>&#8221;) relating to the Public Offering, (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase,
          purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, make any short sale or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock beneficially owned (as such term is used in
          Rule 13d-3 of the 1934 Act) by the undersigned or any other securities so owned that are convertible into or exercisable or exchangeable (directly or indirectly) for, or that represent the right to receive, shares of Common Stock (&#8220;<font style="font-weight: bold;">Other Securities</font>&#8221;) or (2) enter into any swap, hedging transaction or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock or Other
          Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock, Other Securities, in cash or otherwise. The undersigned acknowledges and agrees that the foregoing precludes the
          undersigned from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other
          derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by the undersigned or any other person) of any
          economic consequences of ownership, in whole or in part, directly or indirectly, of any Common Stock or Other Securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of Common
          Stock, Other Securities, in cash or otherwise.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">Notwithstanding the foregoing, the undersigned may transfer the undersigned&#8217;s shares of Common Stock or Other Securities in the following transactions:</div>
        <div>&#160;</div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3ba180a96e854087bdcdd820ef783088" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="text-align: left;">(a)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div>transactions relating to shares of Common Stock or Other Securities acquired in open market transactions after the completion of the Public Offering;</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>&#160;</div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z9c8270f4746c49b4b17826ff272e7576" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="text-align: left;">(b)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div>transfers of shares of Common Stock or Other Securities as a bona fide gift;</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>&#160;</div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z008cee0c5df5476297b26668c50dfb11" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="text-align: left;">(c)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div>transfers of shares of Common Stock or Other Securities as a bona fide gift intended as a charitable donation;</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>&#160;</div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z79a330e0fc004e9da1a710b1b1bc8d2d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="text-align: left;">(d)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div>transfers of shares of Common Stock or Other Securities by will or other testamentary document or by intestacy;</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>&#160;</div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z429a72f02cda40d9b12d49a451b41f23" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="text-align: left;">(e)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div>transfers of shares of Common Stock or Other Securities to any trust, family limited partnership, or other estate planning vehicles for the direct or indirect benefit of the undersigned or the immediate family of the undersigned,
                      or if the undersigned is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes of this agreement, &#8220;immediate family&#8221; shall mean any relationship by blood, current or former
                      marriage, domestic partnership or adoption, not more remote than first cousin);</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>&#160;</div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="za35003e21d2e4969a484a65d64b3e28a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="text-align: left;">(f)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div>transfers of shares of Common Stock or Other Securities to a partnership, limited liability company or other entity of which the undersigned is, or the undersigned&#8217;s family members&#160; (as defined in Section A.1(a)(5) of the General
                      Instructions of Form S-8 under 1933 Act) are, the legal and beneficial owner or owners of all of the outstanding equity securities or similar interests;</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">A-2</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="zd518571904c54984bed2e65022c6c9f0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;"><a name="z_Ref174018588"></a>(g)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>transfers of shares of Common Stock or Other Securities to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (b) through (f) above;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z232fa54ff87c495d9279effd868b0388" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;"><a name="z_Ref174018578"></a>(h)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>distributions of shares of Common Stock or Other Securities to limited partners, members, stockholders, or trust beneficiaries of the undersigned or to any investment fund or other entity controlled or managed by the undersigned;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z51513057476448fd82b62bf83118b92d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;"><a name="z_Ref174018561"></a>(i)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>transfers of shares of Common Stock or Other Securities by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z968724b549804760b0763e7a8797faab" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;"><a name="z_Ref174018797"></a>(j)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>transfers of shares of Common Stock or Other Securities to the Company from a director or an employee of the Company upon death, disability or termination of status as a director or employee of the Company of such individual;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zaa2a2ca5a4b24c41a95416f6479b7a29" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;"><a name="z_Ref174018804"></a>(k)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>transfers of shares of Common Stock or Other Securities to the Company in connection with vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase shares of Common Stock (including, in
                  each case, by way of &#8220;net&#8221; or &#8220;cashless&#8221; exercise), including for the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options, warrants or
                  rights, <font style="font-style: italic;">provided</font> that any such shares of Common Stock received upon such exercise, vesting or settlement shall be subject to the terms of this agreement, and <font style="font-style: italic;">provided</font>&#160;<font style="font-style: italic;">further</font> that any such restricted stock units, options, warrants or rights are held by the undersigned pursuant to an agreement or equity awards granted under a stock incentive plan or other equity
                  award plan, each such agreement or plan which is described in the Registration Statement, the General Disclosure Package and the Prospectus;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z58b3226311734da7b7243bc0266064b7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">(l)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>transfers of shares of Common Stock or Other Securities pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of Directors of the Company and made to all
                  holders of the Company&#8217;s capital stock involving a Change of Control (as defined below) of the Company (for purposes hereof, &#8220;<font style="font-weight: bold;">Change of Control</font>&#8221; shall mean the transfer (whether by tender offer,
                  merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, other than the Company, of shares of capital stock if, after such transfer, such
                  person or group of affiliated persons would become the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the 1934 Act) of at least a majority of the outstanding voting securities of the Company (or the surviving entity)); <font style="font-style: italic;">provided</font> that in the event that such tender offer, merger, consolidation or other similar transaction is not completed, the undersigned&#8217;s shares of Common Stock or Other Securities shall remain subject
                  to the provisions of this agreement;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">A-3</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" id="za683014d591f4a96b44e453324f86665" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;"><a name="z_Ref174018814"></a>(m)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>transfers of shares of Common Stock or Other Securities pursuant to a written trading plan in effect on the date of hereof, which was established pursuant to and in accordance with Rule 10b5-1(c) under the 1934 Act (a &#8220;<u>10b5-1 Plan</u>&#8221;);



                  <font style="font-style: italic;">provided</font> that (i) the undersigned agrees that any such 10b5-1 Plan shall not be amended, waived or otherwise modified during the Restricted Period in a manner that would provide for the transfer of
                  the Shares during the Restricted Period or increase Shares scheduled for sale thereunder during the Restricted Period and (ii) the existence of any such 10b5-1 Plan was communicated to the Representatives prior to the execution of this
                  agreement;</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z10a85312c8414621ac7a21e6ddd9f47b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">(n)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><a name="z_Ref174018548"></a>establishing a 10b5-1 Plan on behalf of a shareholder, officer or director of the Company for the transfer of shares of Common Stock, <font style="font-style: italic;">provided</font> that (i) such plan
                  does not provide for the transfer of Common Stock during the Restricted Period and (ii) to the extent a public announcement or filing under the 1934 Act, if any, is required of or voluntarily made by or on behalf of the undersigned or the
                  Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such plan during the Restricted Period; or</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z85cac1de2ee54645bf6c4db4aaaaa94d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">(o)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><a name="z_Ref174018719"></a>transfers of shares of Common Stock or Other Securities pursuant to an order of a court or regulatory agency.</div>
              </td>
            </tr>

        </table>
        <div>&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> that (A) in the case of any transfer or distribution pursuant to clause (b), (e), (f), (g), (h), (i) and (o), such transfer shall not involve a disposition for value and each donee, devisee, transferee or distributee shall sign and
            deliver a lock up agreement substantially in the form of this agreement (other than pursuant to clauses (i) and (o)), (B) in the case of any transfer or distribution pursuant to clause (a), (b), (c), (d), (e), (f) and (g), no filing under the
            1934 Act or other public announcement shall be required or shall be voluntarily made during the Restricted Period, (C) in the case of any transfer or distribution pursuant to clause (h), no filing under the 1934 Act or other public announcement
            reporting a reduction in beneficial ownership of shares of Common Stock shall be required or shall be voluntarily made during the Restricted Period and (D) in the case of any transfer or distribution pursuant to clause (i), (j), (k), (m), (n)
            and (o), it shall be a condition to such transfer that no public filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the 1934 Act, or other public filing, report or announcement reporting a
            reduction in beneficial ownership of shares of Common Stock in connection with such transfer or distribution shall be legally required during the Restricted Period, such filing, report or announcement shall clearly indicate in the footnotes
            thereto the nature and conditions of such transfer.</font></div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">In addition, the undersigned agrees that, without the prior written consent of the Representatives on behalf of the Underwriters, he, she or it will not, during the Restricted Period, make any
          demand for or exercise any right with respect to, the registration of any shares of Common Stock or Other Securities. The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#8217;s transfer agent and
          registrar against the transfer of the undersigned&#8217;s shares of Common Stock and Other Securities except in compliance with the foregoing restrictions.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">The undersigned understands that the Company and the Underwriters are relying upon this agreement in proceeding toward consummation of the Public Offering. The undersigned further understands
          that this agreement is irrevocable and shall be binding upon the undersigned&#8217;s heirs, legal representatives, successors and assigns.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">A-4</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt;">The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned with
          respect to the Public Offering of the Shares and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although
          the Underwriters may provide certain Regulation Best Interest and Form CRS disclosures or other related documentation to you in connection with the Public Offering, the Underwriters are not making a recommendation to you to participate in the
          Public Offering or sell any Shares at the price determined in the Public Offering, and nothing set forth in such disclosures or documentation is intended to suggest that any Underwriter is making such a recommendation. The undersigned further
          acknowledges and agrees that none of the Underwriters has made any recommendation or provided any investment or other advice to the undersigned with respect to this agreement or the subject matter hereof, and the undersigned has consulted his,
          her or its own legal, accounting, financial, regulatory, tax and other advisors with respect to this agreement and the subject matter hereof to the extent the undersigned has deemed appropriate.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">This agreement shall automatically terminate, and the undersigned will be released from all of his, her or its obligations hereunder, upon the earliest to occur, if any, of (a) the date that the
          Company or the Selling Stockholder advises the Representatives, in writing, prior to the execution of the Underwriting Agreement, that it has determined not to proceed with the Public Offering, (b) the date that the Company withdraws the
          Registration Statement related to the Public Offering before the execution of the Underwriting Agreement, (c) if the Underwriting Agreement is executed but terminated (other than the provisions thereof that survive termination) prior to payment
          for and delivery of the shares of Common Stock to be sold thereunder, the date that the Underwriting Agreement is terminated or (d) August 30, 2024 if the Public Offering of the Shares has not been completed by such date.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">Whether or not the Public Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only be made pursuant to an Underwriting Agreement, the
          terms of which are subject to negotiation between the Company, the Selling Stockholder and the Underwriters.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">This agreement may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the
          Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all
          purposes.</div>
        <div>&#160;</div>
        <div style="text-align: justify; text-indent: 36pt;">This agreement shall be governed by and construed in accordance with the laws of the State of New York.</div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">A-5</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" id="zb5dca8f0e34643eaa1b6f0a3da3555df" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;"><br>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div>Very truly yours,</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;">
                <div>(Signature)</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;">
                <div>(Name)</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <br>
      </div>
    </div>
  </div>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">A-6</font>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>oxy-20240812.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.6.2.5244 Broadridge-->
<xs:schema targetNamespace="http://oxy.com/20240812" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:oxy="http://oxy.com/20240812" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="oxy-20240812_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="oxy-20240812_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="oxy-20240812_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://oxy.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:element name="WarrantsToPurchaseCommonStock020ParValueMember" id="oxy_WarrantsToPurchaseCommonStock020ParValueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>oxy-20240812_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.6.2.5244 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://oxy.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="oxy-20240812.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://oxy.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="oxy-20240812.xsd#oxy_WarrantsToPurchaseCommonStock020ParValueMember" xlink:label="WarrantsToPurchaseCommonStock020ParValueMember" xlink:title="WarrantsToPurchaseCommonStock020ParValueMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="WarrantsToPurchaseCommonStock020ParValueMember" xlink:title="definition: ClassOfStockDomain to WarrantsToPurchaseCommonStock020ParValueMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="definition: ClassOfStockDomain to CommonStockMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>oxy-20240812_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.6.2.5244 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember" xml:lang="en-US" id="us-gaap_CommonStockMember">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain" xml:lang="en-US" id="us-gaap_ClassOfStockDomain">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable" xml:lang="en-US" id="dei_EntityListingsTable">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable" xlink:title="label: EntityListingsTable to dei_EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems" xml:lang="en-US" id="dei_EntityListingsLineItems">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
    <link:loc xlink:type="locator" xlink:href="oxy-20240812.xsd#oxy_WarrantsToPurchaseCommonStock020ParValueMember" xlink:label="WarrantsToPurchaseCommonStock020ParValueMember" xlink:title="WarrantsToPurchaseCommonStock020ParValueMember" />
    <link:label xlink:type="resource" xlink:label="oxy_WarrantsToPurchaseCommonStock020ParValueMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="oxy_WarrantsToPurchaseCommonStock020ParValueMember_lbl1" xml:lang="en-US" id="oxy_WarrantsToPurchaseCommonStock020ParValueMember_lbl1">Warrants to Purchase Common Stock, $0.20 par value [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsToPurchaseCommonStock020ParValueMember" xlink:to="oxy_WarrantsToPurchaseCommonStock020ParValueMember_lbl1" xlink:title="label: WarrantsToPurchaseCommonStock020ParValueMember to oxy_WarrantsToPurchaseCommonStock020ParValueMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>oxy-20240812_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.6.2.5244 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://oxy.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="oxy-20240812.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://oxy.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="oxy-20240812.xsd#oxy_WarrantsToPurchaseCommonStock020ParValueMember" xlink:label="WarrantsToPurchaseCommonStock020ParValueMember" xlink:title="WarrantsToPurchaseCommonStock020ParValueMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="WarrantsToPurchaseCommonStock020ParValueMember" xlink:title="presentation: ClassOfStockDomain to WarrantsToPurchaseCommonStock020ParValueMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="presentation: ClassOfStockDomain to CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139733041002528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 12, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 12,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-9210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">OCCIDENTAL PETROLEUM CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000797468<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4035997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5 Greenway Plaza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">215-7000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=oxy_WarrantsToPurchaseCommonStock020ParValueMember', window );">Warrants to Purchase Common Stock, $0.20 par value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to Purchase Common Stock, $0.20 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OXY WS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.20 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OXY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=oxy_WarrantsToPurchaseCommonStock020ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=oxy_WarrantsToPurchaseCommonStock020ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ (H,.69>*NQS     $P(   L
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "*##EFZ$-B \ 0  .T5   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  B@PY9GZ ;\+$"  #B#   #0              @ $T#0  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( "*##EF7BKL<P    !,"   +
M  "  1 0  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( "*##ED<.&7J/P$  #P"
M   /              "  ?D0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M"  B@PY9)!Z;HJT   #X 0  &@              @ %E$@  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  B@PY999!YDAD!  #/ P
M$P              @ %*$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  "4%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ny20033325x5_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://oxy.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ny20033325x5_8k.htm">ny20033325x5_8k.htm</File>
    <File>oxy-20240812.xsd</File>
    <File>oxy-20240812_def.xml</File>
    <File>oxy-20240812_lab.xml</File>
    <File>oxy-20240812_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20033325x5_8k.htm": {
   "nsprefix": "oxy",
   "nsuri": "http://oxy.com/20240812",
   "dts": {
    "inline": {
     "local": [
      "ny20033325x5_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "oxy-20240812.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "oxy-20240812_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "oxy-20240812_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "oxy-20240812_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 35,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 26
   },
   "report": {
    "R1": {
     "role": "http://oxy.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20240812to20240812",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20033325x5_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20240812to20240812",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20033325x5_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "oxy_WarrantsToPurchaseCommonStock020ParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://oxy.com/20240812",
     "localname": "WarrantsToPurchaseCommonStock020ParValueMember",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to Purchase Common Stock, $0.20 par value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://oxy.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-24-037330-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-037330-xbrl.zip
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M'-;>%,4'&2MA+D#0S:YA !#?N,A"GT;E:$#[AXA38\B[17NMYKM=M9W$?B+
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M,5FZ/+!-SGU?7DX/QO6"9R*)^'0,<7MUK0;90\.)Y]<TY7WA;\DG]?U^FPS
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M-TZ+8A/-+M^K'I\(UN(6-EONBP)6G;4[_/ F@[V].3@ZO[D.]MZ# 71T='0
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M!4.3*17#Q+FD[(_S>]AS!BNHUG)G=VR)U0[IYRV7M+_/@K_9(5\XC#DUU+J
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M;.\;WJO9*(WI+"?JO4;Q[O&IGF 5*$HE$N[/XI0"O2C'N30IYK CXTO@IBE
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M%\\"Y,$K%G7UU!3?J>(VB$.):U9TQ.=)]D U/1Y@=MT=J@P(W,($QNJR%DC
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MM1B493'HLXZK@C<H;JGJ1T&)ZCX,DXI\9ESF@;UN25@^?)E?@WQYGR ;V/@
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M$"9\>G!\$NQI'0VZ MQ,K%G^,"@SK'SNG!":O[TO!<1NT[3<[;J5]1&T&*+
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MLDP"?;Q^]]6/98ZT5HBFR;^ R5X;WT?K1[1&OI3E?20TOH<%LA7:#Z;A_FF
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M/1PN<+2RJ?9!)_N! TX:_X"3I847>BBM,L#/=(/7!K\';KMBZTTTL#$%@#<
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MPGQ(*"$%':ID[L"K_ ^>^5%.3E;ZI]"OZ-\7^CU?HM9N&J2YLZ+V.@EEALX
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MBJ3#G1X(R,<@=M4Z2%5^9,\ R;N^=[-WM#OF;YQO]^ //VQ-OD@;1MW3J:!
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M!R2YB1A"G-);@3D#__6++$T K&L6Q8VB*Q+4C:^1<PL_F9^*H61N.]WJ%_*
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M#&)6L00EFU$\PR1*IX3R@!D5B\<[Z[[K>6DT9KK]Z)8$4@9,6V[8@4Q?<)W
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MFO"7]<G=;):[CR\'BI29@#9[H;+ RIXP,4IOV+Q?I\0_HG0%266'%,+U/M'
M&^26,K&'>D;#*YUSJCU!>UY8+4M[C==5"ZF:^[*T_EM(<FG3?=^'\F+Y/E$^
M68+@1&].OG=S>6+5^,Z__6S;PG_P;PO[\#]02P$"% ,4    "  B@PY9&AV
M4AX6   [D0  $P              @ $     ;GDR,# S,S,R-7@U7SAK+FAT
M;5!+ 0(4 Q0    ( "*##EFRC]Y#&)0  (^A P 6              "  4\6
M  !N>3(P,#,S,S(U>#5?97@Q+3$N:'1M4$L! A0#%     @ (H,.65(J)HW%
M P  ]A   !               ( !FZH  &]X>2TR,#(T,#@Q,BYX<V102P$"
M% ,4    "  B@PY9W3J,0?$&  #M1   %               @ &.K@  ;WAY
M+3(P,C0P.#$R7V1E9BYX;6Q02P$"% ,4    "  B@PY9=5SN/S(*  #@9P
M%               @ &QM0  ;WAY+3(P,C0P.#$R7VQA8BYX;6Q02P$"% ,4
M    "  B@PY9L\?X"?P&  !X30  %               @ $5P   ;WAY+3(P
D,C0P.#$R7W!R92YX;6Q02P4&      8 !@") 0  0\<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ny20033325x5_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:oxy="http://oxy.com/20240812"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="oxy-20240812.xsd" xlink:type="simple"/>
    <context id="c20240812to20240812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797468</identifier>
        </entity>
        <period>
            <startDate>2024-08-12</startDate>
            <endDate>2024-08-12</endDate>
        </period>
    </context>
    <context id="c20240812to20240812_StatementClassOfStockAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797468</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-12</startDate>
            <endDate>2024-08-12</endDate>
        </period>
    </context>
    <context id="c20240812to20240812_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock020ParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000797468</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">oxy:WarrantsToPurchaseCommonStock020ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-12</startDate>
            <endDate>2024-08-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20240812to20240812"
      id="Fact_170e89047b0b404da62c60da4a9e789a">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20240812to20240812"
      id="Fact_c977ddd69e14458782b8e853310497dc">0000797468</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20240812to20240812"
      id="Fact_18534b9f77cd4fac8e23ebb93fd5f0ba">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20240812to20240812"
      id="Fact_13b34413fb5f45eeb540330f8e2ef898">2024-08-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20240812to20240812"
      id="Fact_bd24ba0eae264f12a2af6ccef55e85cf">OCCIDENTAL PETROLEUM CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20240812to20240812"
      id="Fact_41bf4f1e59804a5a8fda037e5ad13780">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20240812to20240812"
      id="Fact_2a4341f3ad3d499b86cc2659bc2dffa3">1-9210</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20240812to20240812"
      id="Fact_5663ed0b9a1947d09b641ee0dbe8adcc">95-4035997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20240812to20240812"
      id="Fact_68f1b567fc784dcaa228f77c386667f4">5 Greenway Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20240812to20240812"
      id="Fact_22e52c80c8fc49b1b10b401e9665238d">Suite 110</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20240812to20240812"
      id="Fact_82768a9586934926a3e70c6d37c27c59">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20240812to20240812"
      id="Fact_e6ac5b56f079477787929f50eed90a6f">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20240812to20240812"
      id="Fact_c37957287bfe4a0f9cf664ae2d2dddab">77046</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20240812to20240812"
      id="Fact_7ea8e735387046fd85094d07f7d75322">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20240812to20240812"
      id="Fact_514e5c49c8f3496ab63bf2fc9d16452b">215-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20240812to20240812"
      id="Fact_19c851fbc23f4488977023bfb3b416e6">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20240812to20240812"
      id="Fact_ba8f53a94ad44e28a93f5b323dc15a0b">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20240812to20240812"
      id="Fact_b595991295c6456fbfb2bf64ae7f528a">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20240812to20240812"
      id="Fact_6ebe48624693476884f22123ed9c8744">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20240812to20240812_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_5c5001f9a66c45a8aba6a1d9a88eeba1">Common Stock, $0.20 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240812to20240812_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_94f287e233ac40fd97fffd47fde0d8f7">OXY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20240812to20240812_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock020ParValueMember"
      id="Fact_d9c45d99ea2d47b1bc8992a924a3e385">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="c20240812to20240812_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock020ParValueMember"
      id="Fact_59cf342c605a482fbc66f16234c42354">Warrants to Purchase Common Stock, $0.20 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240812to20240812_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock020ParValueMember"
      id="Fact_233d4db371bb41d9bd38efd29899e9a0">OXY WS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20240812to20240812_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_8fb9967ecf5e4e1ba49ac1157d6883e3">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20240812to20240812"
      id="Fact_f4905e8ecbea44ac93f22d1b4ca8914e">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
